WO2013084770A1 - Azole derivative, method for producing azole derivative, intermediate compound, drug for agricultural and horticultural applications, and industrial material protectant - Google Patents

Azole derivative, method for producing azole derivative, intermediate compound, drug for agricultural and horticultural applications, and industrial material protectant Download PDF

Info

Publication number
WO2013084770A1
WO2013084770A1 PCT/JP2012/080751 JP2012080751W WO2013084770A1 WO 2013084770 A1 WO2013084770 A1 WO 2013084770A1 JP 2012080751 W JP2012080751 W JP 2012080751W WO 2013084770 A1 WO2013084770 A1 WO 2013084770A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
general formula
azole derivative
carbon atoms
azole
Prior art date
Application number
PCT/JP2012/080751
Other languages
French (fr)
Japanese (ja)
Inventor
大河 正野
須藤 敬一
泰司 三宅
Original Assignee
株式会社クレハ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社クレハ filed Critical 株式会社クレハ
Publication of WO2013084770A1 publication Critical patent/WO2013084770A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647Triazoles; Hydrogenated triazoles
    • A01N43/6531,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Definitions

  • the present invention relates to a novel azole derivative, a method for producing the azole derivative, and an intermediate compound. Moreover, it is related with the agricultural and horticultural chemical
  • the present invention has been made in view of the above problems, and its purpose is to provide a high control effect against plant diseases, and as an active ingredient in agricultural and horticultural medicines with reduced phytotoxicity to plants. It is to provide an azole derivative to be contained.
  • the azole derivative represented by the following general formula (I) and the azole derivative represented by the following general formula (Ia) have excellent activity and phytotoxicity to plants. Has been found to be reduced, and the present invention has been completed.
  • An azole derivative characterized by being represented by the following general formula (I) or (Ia).
  • Y 1 represents a halogen atom
  • R 1 represents an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, or a hydrogen atom
  • Y 2 represents a halogen atom
  • m represents 0, 1 or 2
  • A represents a nitrogen atom or a methine group.
  • X represents —SH, —SR 2 , —SO—R 2 , —SO 2 —R 2 or —SO 3 H.
  • R 2 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a haloalkyl group having 1 to 6 carbon atoms, a haloalkenyl group having 2 to 6 carbon atoms, an aryl group, or an arylalkyl A group (the alkyl part has 1 to 4 carbon atoms), and in the aryl group and arylalkyl group in R 2 , at least one hydrogen atom in the aromatic ring is a halogen atom, and an alkyl group having 1 to 4 carbon atoms (cyclohexane). An alkyl group), or a haloalkyl group having 1 to 4 carbon atoms. ) An intermediate compound used for producing the above azole derivative, which is represented by the following general formula (II) or (IIa).
  • R 1, Y 2, m and A are the same as R 1, Y 2, m and A in each of the above general formula (I) and (Ia).
  • X is the same as X in the general formula (I).
  • R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in General Formula (I), respectively.
  • this invention also includes the agricultural and horticultural chemical
  • the azole derivative according to the present invention has an excellent bactericidal action against many bacteria that cause diseases on plants, and has low phytotoxicity on plants. Therefore, the chemical
  • the azole derivative according to the present invention is an azole derivative represented by the following general formula (I) or (Ia).
  • the azole derivative represented by the general formula (I) is referred to as an azole derivative (I)
  • the azole derivative represented by the general formula (Ia) is referred to as an azole derivative (Ia).
  • Y 1 represents a halogen atom
  • R 1 represents an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, or a hydrogen atom
  • Y 2 represents a halogen atom
  • m represents 0, 1 or 2
  • A represents a nitrogen atom or a methine group.
  • X represents —SH, —SR 2 , —SO—R 2 , —SO 2 —R 2 or —SO 3 H.
  • R 2 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a haloalkyl group having 1 to 6 carbon atoms, a haloalkenyl group having 2 to 6 carbon atoms, an aryl group, or an arylalkyl A group (the alkyl part has 1 to 4 carbon atoms), and in the aryl group and arylalkyl group in R 2 , at least one hydrogen atom in the aromatic ring is a halogen atom, and an alkyl group having 1 to 4 carbon atoms (cyclohexane). An alkyl group), or a haloalkyl group having 1 to 4 carbon atoms.
  • Y 1 represents a halogen atom.
  • the halogen atom for Y 1 include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom, a fluorine atom, a chlorine atom and a bromine atom are more preferred, and a chlorine atom and a bromine atom are more preferred.
  • a chlorine atom is particularly preferred.
  • R 1 represents an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, or a hydrogen atom.
  • the alkyl group having 1 to 3 carbon atoms include a methyl group, an ethyl group, an n-propyl group, and a 1-methylethyl group.
  • the alkoxy group having 1 to 3 carbon atoms include a methoxy group, an ethoxy group, an n-propoxy group, and a 1-methylethoxy group.
  • R 1 is a hydrogen atom.
  • Y 2 represents a halogen atom.
  • the halogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom, among which a fluorine atom, a chlorine atom and a bromine atom are more preferable, and a fluorine atom and a chlorine atom are particularly preferable.
  • n 0, 1 or 2.
  • the bonding position of Y 2 is not particularly limited, but when m is 1, it is preferably a 4-substituted benzyl group.
  • m 2, it is preferably a 2,4-substituted benzyl group.
  • a plurality of Y 2 may be different from each other, but more preferably the same as each other.
  • m is 0 or 1.
  • A represents a nitrogen atom or a methine group.
  • A is a nitrogen atom.
  • X represents —SH, —SR 2 , —SO—R 2 , —SO 2 —R 2 or —SO 3 H.
  • R 2 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a haloalkyl group having 1 to 6 carbon atoms, a haloalkenyl group having 2 to 6 carbon atoms, an aryl group, or an arylalkyl group (Wherein the alkyl moiety has 1 to 4 carbon atoms).
  • alkyl group having 1 to 6 carbon atoms examples include methyl group, ethyl group, n-propyl group, 1-methylethyl group, n-butyl group, 1-methylpropyl group, 2-methylpropyl group, 1,1-dimethyl group.
  • alkenyl group having 2 to 6 carbon atoms examples include ethenyl group, 1-propenyl group, 2-propenyl group, 1-methylethenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-1- Propenyl group, 2-methyl-1-propenyl group, 1-methyl-2-propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-1-butenyl group, 2-methyl-1-butenyl group, 3-methyl-1-butenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 3-methyl-2 -Butenyl group, 1-methyl-3-butenyl group, 2-methyl-3-butenyl group, 3-methyl-3-butenyl group, 1,1-dimethyl-2-propenyl group, 1,2-dimethyl-1- Propeni Group, 1,
  • haloalkyl group having 1 to 6 carbon atoms examples include chloromethyl group, bromomethyl group, dichloromethyl group, trichloromethyl group, fluoromethyl group, difluoromethyl group, trifluoromethyl group, chlorofluoromethyl group, dichlorofluoromethyl group, chloro Difluoromethyl group, 1-chloroethyl group, 1-bromoethyl group, 1-fluoroethyl group, 2-fluoroethyl group, 2,2-difluoroethyl group, 2,2,2-trifluoroethyl group, 2-chloro-2 -Fluoroethyl group, 2-chloro-2,2-difluoroethyl group, 2,2-dichloro-2-fluoroethyl group, 2,2,2-trichloroethyl group, pentafluoroethyl group and the like.
  • haloalkenyl group having 2 to 6 carbon atoms examples include 2-chloroethenyl group, 2,2-dichloroethenyl group, 2-chloro-2-propenyl group, 3,3-dichloro-2-propenyl group, 2,3-dichloro -2-propenyl group, 3,3-dichloro-2-methyl-2-propenyl group, 3-chloro-2-butenyl group, 2-fluoroethenyl group, 2,2-difluoroethenyl group, 2-fluoro- 2-propenyl group, 3,3-difluoro-2-propenyl group, 2,3-difluoro-2-propenyl group, 3,3-difluoro-2-methyl-2-propenyl group, 3-fluoro-2-butenyl group 2-bromoethenyl group, 2,2-dibromoethenyl group, 2-bromo-2-propenyl group, 3,3
  • arylalkyl group (the alkyl part has 1 to 4 carbon atoms), phenylmethyl group, phenylnaphthyl group, 1-phenylethyl group, 2-phenylethyl group, 2-naphthylethyl group, 1-phenylpropyl group, 2 -Phenylpropyl group, 3-phenylpropyl group, 1-methyl-2-phenylethyl group, 1-methyl-1-phenylethyl group, 4-phenylbutyl group and the like can be mentioned.
  • aryl group examples include a phenyl group, a naphthyl group, a biphenyl group, an anthryl group, and a phenanthryl group.
  • One, two or three of the hydrogen atoms in the aromatic ring of the aryl group and arylalkyl group for R 2 are a halogen atom, an alkyl group having 1 to 4 carbon atoms (including a cycloalkyl group), or 1 to It may be substituted with 4 haloalkyl groups.
  • the alkyl group having 1 to 4 carbon atoms as a substituent includes a methyl group, an ethyl group, an n-propyl group, a 1-methylethyl group, an n-butyl group, a 1-methylpropyl group, and a 2-methylpropyl group. 1,1-dimethylethyl group, cyclopropylmethyl group and the like.
  • examples of the haloalkyl group having 1 to 4 carbon atoms as a substituent include a trifluoromethyl group, a pentafluoroethyl group, a chloromethyl group, a trichloromethyl group, and a bromomethyl group. More preferred are fluorine atom, chlorine atom, bromine atom, methyl group, ethyl group, trifluoromethyl group and chloromethyl group.
  • the azole derivative (Ia) is a tautomeric form (“thiono” form) of an azole derivative (“mercapto” form) represented by the following general formula (Ib) in which X in the general formula (I) is —SH. is there.
  • R 1, Y 1, Y 2, m and A are each the same as R 1, Y 1, Y 2 , m and A in the general formula (I).
  • azole derivatives according to the present invention include, but are not limited to, azole derivatives represented by the following general formula (Ic) or (Id).
  • R 1, Y 1, Y 2 and A are the same as R 1, Y 1, Y 2 and A in each of the above general formula (I) and (Ia)
  • X is the same as X in general formula (I) above.
  • specific examples of the azole derivative according to the present invention include azole derivatives represented by the following general formula (Ie).
  • Y 3 represents a hydrogen atom, a fluorine atom or a chlorine atom.
  • Y 3 represents a hydrogen atom, a fluorine atom or a chlorine atom.
  • an azole derivative in which a hydroxy group bonded to a cyclopentane ring and a halomethyl group are in cis form is preferable, and a hydroxy group bonded to a cyclopentane ring and a halomethyl group and a substituted or unsubstituted benzyl group are in cis form.
  • An azole derivative which is a type is more preferable.
  • azole derivative (III) an azole derivative represented by the following general formula (III) (hereinafter referred to as azole derivative (III)) is a starting material. Can be manufactured as. A method for producing the azole derivative (III) will be described later.
  • R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in general formula (I), respectively.
  • reaction (a) a method in which the azole derivative (III) is successively reacted with a strong base and sulfur in the presence of a diluent and then the product is hydrolyzed with water (reaction (a)), or the azole derivative (III) is used.
  • an azole derivative represented by the following general formula (IIa) (hereinafter referred to as azole derivative (IIa)), or the following general formula (IIb) Is obtained (hereinafter referred to as azole derivative (IIb)).
  • reaction (a) and reaction ( b) will be described as a method for producing the azole derivative (IIa), and the oxetane ring opening reaction will be described as a method for producing the azole derivative (Ia) from the azole derivative (IIa).
  • reaction (a) In the reaction (a), the azole derivative (IIIa) is obtained by sequentially reacting the azole derivative (III) with a strong base and sulfur in the presence of a diluent, and then hydrolyzing the product with water.
  • Strong bases can include all strong alkali metal bases commonly used in similar reactions, such as n-butyllithium, lithium diisopropylamide, sodium hydride and sodium amide, and tetramethylethylenediamine ( Potassium t-butoxide as a mixture with TMEDA) can preferably be used.
  • Diluents can include all inert organic solvents commonly used in similar reactions, such as ethers such as tetrahydrofuran (THF), dioxane, diethyl ether and 1,2-dimethoxyethane, In addition, a strong polar solvent such as liquid ammonia or dimethyl sulfoxide can be preferably used.
  • ethers such as tetrahydrofuran (THF), dioxane, diethyl ether and 1,2-dimethoxyethane
  • a strong polar solvent such as liquid ammonia or dimethyl sulfoxide can be preferably used.
  • the amount of sulfur used is, for example, 1 to 5 mol of sulfur, and preferably 1 to 1.5 mol of sulfur with respect to 1 mol of azole derivative (III). Sulfur is preferably used in a powder state.
  • Hydrolysis in reaction (a) may be carried out in the presence of an acid, which can include all inorganic or organic acids commonly used in similar reactions, such as acetic acid, Dilute sulfuric acid and dilute hydrochloric acid can be preferably used.
  • an acid which can include all inorganic or organic acids commonly used in similar reactions, such as acetic acid, Dilute sulfuric acid and dilute hydrochloric acid can be preferably used.
  • the hydrolysis can also be carried out using an aqueous ammonium chloride solution.
  • the reaction temperature in the reaction (a) is, for example, ⁇ 70 ° C. to 20 ° C., preferably ⁇ 70 ° C. to 0 ° C.
  • the produced azole derivative (IIa) may be separated and purified by a conventional method such as recrystallization and chromatography.
  • reaction (b) In the reaction (b), the azole derivative (IIa) is obtained by reacting the azole derivative (III) in the presence of sulfur powder and dimethylformamide.
  • the azole derivative (IIa) When the azole derivative (IIa) is produced by the reaction (b), the azole derivative (III) can be diluted with a diluent.
  • a diluent Any conventional aprotic polar organic solvent can be used as the diluent.
  • amides such as dimethylformamide
  • N-alkyl-pyrrolidones such as N-octyl-pyrrolidone and N-dodecyl-pyrrolidone
  • N-alkyl-caprolactams such as N-methyl-caprolactam and N-octyl-caprolactamkind.
  • the reaction temperature can be varied within a certain range, for example, a temperature of 140 ° C. to 200 ° C., preferably 150 ° C. to 160 ° C.
  • the reaction can be carried out at atmospheric pressure or under pressure.
  • the amount of sulfur used is, for example, 6 to 15 mol of sulfur, and preferably 8 to 13 mol of sulfur with respect to 1 mol of azole derivative (III).
  • the azole derivative (IIa) produced may be separated and purified by a conventional method such as recrystallization and chromatography.
  • the azole derivative (Ia) is obtained.
  • a method for opening the oxetane ring a method in which an azole derivative (IIa) and a halogen acid are mixed in a solvent to generate a halogenated methyl group and a tertiary hydroxy group is preferably used.
  • halogen acid examples include hydrogen fluoride, hydrogen chloride, hydrogen bromide, and hydrogen iodide. Of these, hydrogen chloride and hydrogen bromide are preferably used.
  • the halogen acid may be introduced as a gas, or may be added after being dissolved in an organic solvent. By adding a halide salt (for example, lithium chloride and sodium chloride) and another acid (for example, Bronsted acid such as toluenesulfonic acid, methanesulfonic acid and sulfuric acid, or Lewis acid such as aluminum chloride).
  • the azole derivative (Ia) may be obtained from the azole derivative (IIa) by generating a halogen acid in the system.
  • the solvent is not particularly limited, and examples thereof include amides such as N-methylpyrrolidone and N, N-dimethylformamide, alcohols such as methanol and ethanol, ethers such as tetrahydrofuran and dioxane, and water. Of these, dimethylformamide, methanol, water and dioxane are preferably used.
  • the amount of the halogen acid is, for example, 0.5 to 50 times mol, preferably 1 to 20 times mol with respect to the azole derivative (IIa).
  • the reaction temperature can be appropriately set depending on the solvent used and the like, and is, for example, ⁇ 20 ° C. to 250 ° C., preferably ⁇ 10 ° C. to 150 ° C., particularly 50 ° C. to 80 ° C. preferable.
  • the reaction time can be appropriately set depending on the solvent used and the like. For example, the reaction time is 0.1 hour to several days, and preferably 1 hour to 48 hours.
  • the 1-position becomes a tertiary hydroxy group and the 2-position becomes a halogenated methyl group.
  • the following general formula (I) can be obtained from the azole derivative (IIa) or azole derivative (IIb) by the following reaction (c), (d) or (e). IIc) is synthesized (hereinafter referred to as azole derivative (IIc)), and the azole derivative (IIc) is reacted with a halogen acid to open the oxetane ring of the azole derivative (IIc).
  • Other azole derivatives (I) other than the derivative (Ib) can be obtained.
  • R 1, Y 2, m and A are each the same as R 1, Y 2, m and A in the general formula (I)
  • X 1 is -SR 2
  • -SO -R 2 -SO 2 -R 2 or -SO 3 H
  • R 2 is the same as R 2 in the general formula (I).
  • the reactions (c), (d), and (e) when the azole derivative (IIa) is used will be described.
  • the ring-opening reaction after reaction (c), (d) or (e) is the same as the ring-opening reaction at the time of obtaining azole derivative (Ia), description mentioned above can be used.
  • reaction (c) In reaction (c), the azole derivative (IIa) is converted to a compound of the general formula (IV) in the presence of an acid binder and a diluent.
  • R 3 -L .. (IV) In the general formula (IV), R 3 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a haloalkyl group having 1 to 6 carbon atoms, or a halo having 2 to 6 carbon atoms.
  • An alkenyl group or an arylalkyl group (the alkyl moiety has 1 to 4 carbon atoms).
  • L represents a halogen atom.
  • X 1 is —SR 2 (wherein R 2 is an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, or 1 to 6 carbon atoms).
  • R 2 is an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, or 1 to 6 carbon atoms.
  • An azole derivative (IIc) is obtained, which is a haloalkyl group, a haloalkenyl group having 2 to 6 carbon atoms, or an arylalkyl group (wherein the alkyl moiety has 1 to 4 carbon atoms).
  • R 3 alkyl group having 1 to 6 carbon atoms, alkenyl group having 2 to 6 carbon atoms, haloalkyl group having 1 to 6 carbon atoms, haloalkenyl group having 2 to 6 carbon atoms, arylalkyl group (alkyl moiety) 1 to 4) has the same meaning as those of R 2 .
  • L represents a halogen atom, and examples thereof include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom.
  • acid binders include all commonly used inorganic bases and organic bases, such as alkali metal hydroxides or alkaline earth metal waters such as sodium hydroxide, calcium hydroxide and potassium hydroxide.
  • DABCO diazabicyclooctane
  • DBN diazab
  • Diluents can include all commonly used organic solvents such as diethyl ether, methyl t-butyl ether, ethylene glycol dimethyl ether, ethers such as tetrahydrofuran and dioxane, nitriles such as acetonitrile, and the like.
  • a polar solvent such as dimethyl sulfoxide or dimethylformamide can be suitably used.
  • the reaction temperature is, for example, 0 ° C. to 120 ° C., preferably 20 ° C. to 100 ° C.
  • the amount of the halide represented by the general formula (IV) is, for example, 1 to 2 mol with respect to 1 mol of the azole derivative (IIa).
  • the acid binder for example, an equivalent amount or an excess amount of the azole derivative (IIa) can be used.
  • reaction (d) In the reaction (d), the azole derivative (IIa) obtained is sequentially converted into a strong base and a compound represented by the general formula (V) R 4 —S—S—R 4 (V) (In general formula (V), R 4 represents an aryl group.) To obtain an azole derivative (IIc) in which X 1 is —SR 2 (where R 2 represents an aryl group).
  • the aryl group in R 4 has the same meaning as the aryl group in R 2 described above.
  • the strong base and diluent As the strong base and diluent, the strong base and diluent exemplified in the description of the reaction (a) can be used.
  • reaction (e) In reaction (e), azole derivative (IIc) in which X 1 is —SO 3 H, —SO 2 R 2 or —SOR 2 is obtained by reacting azole derivative (IIa) in the presence of an oxidizing agent and a diluent. Get. In the reaction (e), an azole derivative (IIc) in which X 1 is —SR 2 can be used instead of the azole derivative (IIa).
  • the oxidizing agent can include all substances commonly used for the oxidation of sulfur, such as hydrogen peroxide; peracids such as peracetic acid and metachloroperbenzoic acid; and inorganic salts such as potassium permanganate. Can be suitably used.
  • Diluents can include all solvents commonly used in similar reactions.
  • acetic acid or glacial acetic acid can be suitably used as the diluent.
  • potassium permanganate is used as the oxidizing agent, water or alcohol such as t-butanol can be preferably used.
  • the reaction temperature is, for example, 0 ° C. to 100 ° C., preferably 10 ° C. to 100 ° C.
  • the oxidant is preferably used in an equivalent amount relative to the azole derivative (IIc) in which X 1 is —SR 2 .
  • the oxidant is preferably used in an excess amount relative to the azole derivative (IIc) in which X 1 is —SR 2 .
  • azole derivative (I) other than azole derivative (Ib) from azole derivative (IIa) or azole derivative (IIb)
  • the manufacturing method of azole derivative (I) is limited to this.
  • the azole derivative (Ia) or the azole derivative (Ib) with the reaction similar to the above reaction (c), (d) or (e), other than the azole derivative (Ib)
  • the azole derivative (I) may be produced.
  • the azole derivative (IIa) and the azole derivative (IIb) obtained by the reaction (a) or the reaction (b) and the azole derivative (IIc) obtained by the reaction (c), the reaction (d) or the reaction (e). ) Is suitably used for the production of the azole derivative (I) as an intermediate compound for producing the azole derivative (I). Therefore, the azole derivative (IIa) and the azole derivative (II) represented by the following general formula (II) are also included in the category of the present invention as suitable intermediate compounds for producing the azole derivative (I).
  • R 1, X , Y 2, m and A are each the same as R 1, X, Y 2, m and A in the general formula (I).
  • a method for producing the azole derivative (I) including a step of obtaining the azole derivative (I) by reacting the azole derivative (II) with a halogen acid is also included in the scope of the present invention.
  • the azole derivative (III) in which R 1 is an alkyl group or a hydrogen atom may be a compound produced by a known method (for example, the method described in Patent Document 1).
  • azole derivative (IIIa) an azole derivative in which R 1 is an alkoxy group
  • azole derivative (VII) is represented by the following general formula (VII) by, for example, each step shown in Reaction Scheme 2.
  • Azole derivative hereinafter referred to as azole derivative (VII)
  • azole derivative (VII) what is necessary is just to use the compound manufactured by a well-known method (for example, the method of patent document 1) as azole derivative (VII).
  • azole derivative (VI) is closed to obtain an azole derivative represented by the general formula (VI) (hereinafter referred to as azole derivative (VI)).
  • a preferred method for synthesizing the azole derivative (VI) by ring closure includes a method of reacting the azole derivative (VII) in a solvent in the presence of a sulfonyl chloride and an excess amount of a base.
  • sulfonyl chlorides p-toluenesulfonyl chloride, methanesulfonyl chloride and the like can be used. Of these, p-toluenesulfonyl chloride is preferably used.
  • the base is not particularly limited, and examples thereof include metal hydride compounds such as sodium hydride, and alkali metal alkoxides such as sodium methoxide, sodium ethoxide, sodium t-butoxide and potassium t-butoxide. It can be used suitably. Among these, sodium hydride can be used more suitably.
  • the amount of sulfonyl chlorides is preferably 1 to 2 moles relative to the azole derivative (VII).
  • the amount of the base is preferably 2.5 to 10-fold mol, more preferably 2.8 to 6-fold mol based on the azole derivative (VII).
  • the solvent is not particularly limited.
  • amides such as N-methylpyrrolidone and N, N-dimethylformamide
  • ethers such as tetrahydrofuran and dioxane, dimethyl sulfoxide, and a mixed solvent thereof can be used.
  • tetrahydrofuran can be preferably used.
  • the reaction temperature can be appropriately set depending on the type of solvent, azole derivative (VII), sulfonyl chlorides, base and the like used, but is preferably ⁇ 100 ° C. to 200 ° C., more preferably ⁇ 50 ° C. ⁇ 150 ° C.
  • the reaction time can be appropriately set depending on the type of solvent, azole derivative (VII), sulfonyl chlorides, base and the like to be used, but is preferably 0.1 hour to several days, more preferably 0. 5 hours to 2 days.
  • the azole derivative (IIIa) is obtained by alkylating the hydroxy group of the azole derivative (VI).
  • R 5 is an alkyl group having 1 to 3 carbon atoms.
  • the alkylation method is not particularly limited, but a metal alkoxide prepared from a hydroxy group of the azole derivative (VI) and an alkali metal base in a solvent is converted to an alkyl compound having 1 to 3 carbon atoms having a leaving group. The method of making it react at room temperature can be mentioned.
  • Solvents include ether solvents such as tetrahydrofuran, amide solvents such as N-methylpyrrolidone and N, N-dimethylformamide, aromatic solvents such as benzene and toluene, and halide solvents such as methylene chloride. Can be suitably used. Of these, tetrahydrofuran can be more preferably used.
  • alkyl compound having 1 to 3 carbon atoms having a leaving group examples include alkyl halides such as alkyl iodide and alkyl bromide in which alkyl has 1 to 3 carbon atoms, and tosyl in which alkyl has 1 to 3 carbon atoms. Mention may be made of sulfonate esters such as oxyalkyl and mesyloxyalkyl. Of these, alkyl iodide can be preferably used. Furthermore, among alkyl iodides, it is more preferable to use methyl iodide.
  • alkali metal base examples include sodium, sodium hydride, sodium hydroxide, and potassium hydroxide. Of these, sodium hydride is preferably used.
  • Plant disease control effect The azole derivatives (I) and (Ia) exhibit a control effect on a wide range of plant diseases.
  • applicable diseases include: soybean rust (Phakopsora pachyrhizi, Phakopsora meibomiae), rice blast (Pyricularia grisea), rice sesame leaf (Cochliobolus miyabeanus), rice leaf blight (Xanthomonas oryzae), rice crest Blight (Rhizoctonia solani), rice small black rot (Helminthosporium sigmoideun), rice seedling disease (Gibberella fujikuroi), rice seedling blight (Pythium aphanidermatum), apple powdery mildew (Podosphaeraleucotricha), apple black infestation (Ventia qualia) ), Apple morinia disease (Moniliniamali), apple spotted leaf disease (Alternaria alternata), apple rot disease (Valsa mali), Pe
  • grape rust Phakopsora ampelopsidis
  • watermelon vine Fusarium oxysporumf.sp.niveum
  • cucumber vine Feusarim oxysporumf.sp.cucumerinum
  • radish yellow Fusarium oxysporumf.sp.raphani
  • Tobacco red streak Alternaria longipes
  • potato summer rot Alternaria solani
  • soybean brown spot Septoria glycines
  • soybean purpura Cercospora kikuchii
  • Examples of applicable plants include wild plants, plant cultivars, plants and plant cultivars obtained by conventional biological breeding such as crossbreeding or protoplast fusion, and genetically modified plants and plant cultivars obtained by genetic manipulation. Is mentioned.
  • Examples of genetically modified plants and plant cultivars include herbicide-tolerant crops, pest-tolerant crops incorporating insecticidal protein production genes, disease-resistant crops incorporating resistance-inducing substance production genes against diseases, food-enhancing crops, and yield improvement Examples include crops, crops with improved shelf life and crops with improved yield.
  • Specific examples of genetically modified plant cultivars include those containing registered trademarks such as ROUNDUP READY, LIBERTY LINK, CLEARFIELD, YIELDGARD, HERCULEX, BOLLGARD and the like.
  • the azole derivatives (I) and (Ia) have the effect of increasing the yield by adjusting the growth and the effect of improving the quality of a wide variety of crops and horticultural plants.
  • crops include: wheat, barley, buckwheat and other wheat, rice, rapeseed, sugarcane, corn, maize, soybeans, peas, peanuts, sugar beet, cabbage, garlic, radish, carrots, apples, pears
  • Citrus fruits such as oranges, oranges, lemons, peaches, cherry peaches, avocados, mangoes, papayas, peppers, cucumbers, melons, strawberries, tobacco, tomatoes, eggplants, grass, chrysanthemums, azaleas, and other ornamental plants.
  • the azole derivatives (I) and (Ia) exhibit an excellent effect of protecting the material from a wide range of harmful microorganisms that invade the industrial material.
  • microorganisms include: Aspergillus sp., Trichoderma sp., Penicillium sp., Geotrichum sp., Which are paper and pulp-degrading microorganisms (including slime-forming bacteria).
  • Rhizopus sp. Rhizopus sp., Aureobasidium sp., Aspergillus sp. And Penicillium sp., Skin-degrading microorganisms, such as Gliocladum sp., Cladosporium sp., Chaetomium sp., And Trichoderma sp. , Ketomium (Chaetomium sp.), Cladosporium (Cl.sporium sp.), Mucor (Mucor sp.), Paecilomyces sp., Pilobus (Pilobus sp.), Pullularia (Pullularia sp.), Trichosporon sp.
  • Gliocladum sp. Cladosporium sp.
  • Chaetomium sp. Chaetomium sp.
  • Trichoderma sp. Ketomium (Chaetomium s
  • Penicillium sp. Penicillium sp., Rhizopus sp., Trichoderma sp., Trichoderma sp., And Chaetomium sp, such as Tricothecium sp. .), Myrothecium sp., Streptomyces sp. Demonas (Pseudomonas sp.), Bacillus (Bacillus sp.), Micrococcus (Micrococcus sp.), Serratia (Serratia sp.), Margarinomyces sp., And Monascus sp.
  • azole derivative (I) or (Ia) as an active ingredient of an agricultural or horticultural agent, it may be left as it is without adding any other components, but usually a solid carrier or a liquid carrier, a surfactant. And mixed with other formulation adjuvants, etc. to be used in various forms such as powders, wettable powders, granules and emulsions.
  • These preparations contain 0.1 to 95% by weight, preferably 0.5 to 90% by weight, more preferably 2 to 80% by weight, of the azole derivative (I) or (Ia) as an active ingredient. To do.
  • solid carriers liquid carriers (liquid diluents) and surfactants used as formulation adjuvants
  • liquid diluents include talc, kaolin, bentonite, diatomaceous earth, white carbon, and clay as solid carriers.
  • the liquid diluent include water, xylene, toluene, chlorobenzene, cyclohexane, cyclohexanone, dimethyl sulfoxide, dimethylformamide and alcohol.
  • surfactants should be properly used depending on their effects.
  • emulsifiers include polyoxyethylene alkylaryl ether and polyoxyethylene sorbitan monolaurate.
  • Dispersants include lignin sulfonate and dibutyl naphthalene.
  • the wetting agent include alkyl sulfonates and alkyl phenyl sulfonates.
  • concentration of the azole derivative (I) when diluted is preferably in the range of 0.001 to 1.0%.
  • the amount of the azole derivatives (I) and (Ia) used is 20 to 5000 g, more preferably 50 to 2000 g per 1 ha of agricultural and horticultural lands such as fields, fields, orchards and greenhouses. Since these use concentrations and amounts vary depending on the dosage form, use time, use method, use place, target crop, etc., they can be increased or decreased without sticking to the above range.
  • azole derivatives (I) and (Ia) are combined with other active ingredients such as fungicides, insecticides, acaricides and herbicides as exemplified below to enhance performance as agricultural and horticultural agents. Can also be used.
  • ⁇ Antimicrobial substances Acibenzolar S-methyl, 2-phenylphenol (OPP), azaconazole, azoxystrobin, amisulbrom, bixaphene, benalaxyl, benomyl, bench avaricarb-isopropyl, bicarbonate, biphenyl, viteltanol, blasticidin-S, borax, bordeaux, boscalid, Bromuconazole, bronopol, bupirimate, secbutyramine, calcium polysulfide, captafor, captan, carbendazim, carboxin, carpropamide, quinomethionate, chloronebu, chloropicrin, chlorothalonil, clozolinate, cyazofamide, cyflufenamide, simoxanil, cyproconil, cyprodiazole Dazomet, debacarb, diclofuranide, diclocimet, dicro Gin, Dichlorane, Diet
  • ⁇ Insecticide / acaricide / nematicide> Abamectin, Acephate, Acrinathrin, Alanicarb, Aldicarb, Alletrin, Amitraz, Avermectin, Azadirachtin, Azamethifos, Azinphos-ethyl, Azinphos-methyl, Azocycline, Bacillus filmus, Bacillus subtilis, Bacillus thuringibulbbenthulbenbencarb , Benzoxymate, Bifenazite, Bifenthrin, Bioarethrin, Bioresmethrin, Bistriflurone, Buprofezin, Butocaboxin, Butoxycarboxyne, Kazusafos, Carbaryl, Carbofuran, Carbosulfan, Cartap, CGA50439, Chlordein, Chloretifol, Chlorfenapir Fenbinfoss,
  • the azole derivative (I) or (Ia) as an active ingredient of an industrial material protective agent, it may be used alone without adding other ingredients, but generally it can be dissolved in a suitable liquid carrier. Alternatively, it is dispersed or mixed with a solid carrier, and if necessary, an emulsifier, a dispersing agent, a spreading agent, a penetrating agent, a wetting agent, a stabilizer and the like are added, and a wettable powder, powder, granule, tablet It can be used as dosage forms such as pastes, suspensions and sprays. Moreover, you may mix
  • any liquid may be used as long as it does not react with the active ingredient.
  • water alcohols (for example, methyl alcohol, ethyl alcohol, ethylene glycol, and cellosolve), ketones (for example, acetone, and Methyl ethyl ketone, etc.), ethers (eg, dimethyl ether, diethyl ether, dioxane, and tetrahydrofuran), aromatic hydrocarbons (eg, benzene, toluene, xylene, and methylnaphthalene), aliphatic hydrocarbons (eg, gasoline, Kerosene, kerosene, machine oil, fuel oil, etc.), acid amides (eg, dimethylformamide, N-methylpyrrolidone, etc.), halogenated hydrocarbons (eg, chloroform, carbon tetrachloride, etc.), esters ( For example, acetate Glycol ester, and glycer
  • fine powders or granular materials such as kaolin clay, bentonite, acid clay, pyrophyllite, talc, diatomite, calcite, urea and ammonium sulfate can be used.
  • surfactants such as soaps, alkylsulfonic acids, alkylarylsulfonic acids, dialkylsulfosuccinic acids, quaternary ammonium salts, oxyalkylamines, fatty acid esters, polyalkylene oxides and anhydrosorbitolscan be used.
  • the content ratio varies depending on the dosage form and the intended purpose, but in general, the concentration is 0.1 to 99.9% by weight. It is appropriate to add as follows. In actual use, the treatment concentration is usually adjusted to 0.005 to 5% by weight, preferably 0.01 to 1% by weight, by appropriately adding a solvent, a diluent, an extender and the like. It is preferable to do this.
  • the azole derivatives (I) and (Ia) exhibit an excellent bactericidal action against many fungi that cause plant diseases.
  • the azole derivatives (I) and (Ia) have little phytotoxicity to plants. That is, by including the azole derivative (I) or (Ia) as an active ingredient, it is low in toxicity to human livestock, has excellent handling safety, exhibits a high control effect on a wide range of plant diseases, and has little phytotoxicity. A disease control agent can be realized.
  • the azole derivative according to the present invention is an azole derivative characterized by being represented by the following general formula (I) or (Ia).
  • Y 1 represents a halogen atom
  • R 1 represents an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, or a hydrogen atom
  • Y 2 represents a halogen atom
  • m represents 0, 1 or 2
  • A represents a nitrogen atom or a methine group.
  • X represents —SH, —SR 2 , —SO—R 2 , —SO 2 —R 2 or —SO 3 H.
  • R 2 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a haloalkyl group having 1 to 6 carbon atoms, a haloalkenyl group having 2 to 6 carbon atoms, an aryl group, or an arylalkyl A group (the alkyl part has 1 to 4 carbon atoms), and in the aryl group and arylalkyl group in R 2 , at least one hydrogen atom in the aromatic ring is a halogen atom, and an alkyl group having 1 to 4 carbon atoms (cyclohexane). An alkyl group), or a haloalkyl group having 1 to 4 carbon atoms. )
  • Y 1 is preferably a chlorine atom.
  • the azole derivative according to the present invention may also be an azole derivative represented by the following general formula (Ic) or (Id).
  • R 1, Y 1, Y 2 and A are the same as R 1, Y 1, Y 2 and A in each of the above general formula (I) and (Ia)
  • X is the same as X in general formula (I) above.
  • A is preferably a nitrogen atom.
  • the azole derivative according to the present invention is preferably an azole derivative represented by the following general formula (Ie).
  • the intermediate compound according to the present invention is an intermediate compound used for producing the above-mentioned azole derivative, and is a compound represented by the following general formula (II) or (IIa).
  • R 1, Y 2, m and A are the same as R 1, Y 2, m and A in each of the above general formula (I) and (Ia).
  • X is the same as X in the general formula (I).
  • A is preferably a nitrogen atom.
  • the method for producing an azole derivative according to the present invention is a method for producing the above azole derivative,
  • the composition includes a step of reacting an intermediate compound represented by the following general formula (II) or (IIa) with a halogen acid to obtain an azole derivative represented by the above general formula (I) or (Ia).
  • R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in General Formula (I), respectively.
  • the manufacturing method of the azole derivative which concerns on this invention makes the compound shown by the following general formula (III) react with sulfur, the compound shown by the following general formula (IIa), or the compound shown by the following general formula (IIb) It is preferable to include the process of obtaining.
  • R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in general formula (I), respectively.
  • R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in the general formula (I), respectively.
  • this invention also includes the agricultural and horticultural chemical
  • reaction solution was filtered to remove insolubles, and the filtrate was dried under reduced pressure.
  • Toluene and 10% aqueous sodium hydroxide solution were added to the residue, and the precipitated pink solid was filtered and washed with toluene.
  • a 1M sulfuric acid aqueous solution and ethyl acetate were added to the solid, and the organic layer was separated. This organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate.
  • iodomethane 0.0112 ml of iodomethane was added and stirred at the same temperature for 5 hours, 0.0112 ml of iodomethane and 7.2 mg of sodium hydride were added, and the mixture was stirred at room temperature for 15 hours, further stirred at 50 ° C. for 4 hours, and further, iodomethane was added in 0.1. 0112 ml and sodium hydride 7.2 mg were added and stirred for 1.5 hours. After completion of the reaction, water was added, extracted with ethyl acetate, and washed with saturated brine.
  • (Wettable powder) Compound (1) 50 parts lignin sulfonate 5 parts alkyl sulfonate 3 parts diatomaceous earth 42 parts were pulverized and mixed to obtain a wettable powder and diluted with water for use.
  • Example 1 Cucumber gray mold control effect test by foliar spray treatment> A hydrated form of compound (1) as shown in the above formulation example in a cotyledon stage cucumber (variety: SHARP1) cultivated using a square plastic pot (6 cm ⁇ 6 cm) with water at a predetermined concentration (100 mg / L) was diluted and suspended at a rate of 1,000 L / ha. The sprayed leaves were air-dried and then placed on a paper disk (diameter 8 mm) soaked with a spore solution of gray mold fungus and kept at 20 ° C. under high humidity.
  • Control value (%) (1 ⁇ (average morbidity in sprayed area / average illness in non-sprayed area)) ⁇ 100
  • control value was 90% or more.
  • ⁇ Test Example 2 Wheat red rust control effect test by foliar spray treatment>
  • a compound (1) in the form of a wettable powder as in Formulation Example 1 is washed with water.
  • the suspension was diluted to a predetermined concentration (12.5 mg / L) and sprayed at a rate of 1,000 L / ha.
  • the sprayed leaves were air-dried and then spray-inoculated with spores of wheat red rust fungus (adjusted to 200 cells / field of view, added with Grameen S to a final concentration of 60 ppm), and kept at 25 ° C. under high humidity for 48 hours.
  • Control value (%) (1 ⁇ (average morbidity in sprayed area / average illness in non-sprayed area)) ⁇ 100
  • control value was 90% or more.
  • Example 3 Evaluation test for phytotoxicity of wheat growth suppression by seed treatment> By pot test, the phytotoxicity of growth suppression by seed treatment was evaluated. After the compound (1) dissolved in DMSO so that the treatment amount is 20 or 200 g ai / 100 kg seeds is smeared on the wheat seeds (variety: Norin 61) in a vial, 8 wheat seeds in 80 cm 2 pots Sowing. The lower water supply was controlled in a greenhouse, and the plant height of wheat was investigated 15 days after sowing. As a control, a test was conducted using the compound (9) represented by the following formula (IX) and metconazole instead of the compound (1) or without using any drug. The results are shown in Table 3.
  • necrosis was observed, slight necrosis was observed in the plant body at any treatment amount when the compound (9) was used.
  • metconazole at a treatment amount of 200 g ai / 100 kg seeds, slight necrosis was observed in the plant body, whereas when using compound (1), necrosis was observed at any treatment amount. was not observed.
  • ⁇ Test Example 4 Test for evaluating phytotoxicity of growth inhibition for soybean> The pot test evaluated the phytotoxicity of growth inhibition by foliar spray treatment.
  • a soybean (cultivar: Enrei) cultivated using a square plastic pot (6 cm x 6 cm), a compound (1) in the form of a wettable powder as in Formulation Example 1, with water at a predetermined concentration (500 mg / L) Diluted and suspended at a rate of 1000 L / ha.
  • the sprayed leaves were air-dried and managed in a greenhouse.
  • the plant height of soybean was measured on the 13th day after the spraying of the drug.
  • the test was performed using compound (9) instead of compound (1) or without using any drug. The results are shown in Table 4.
  • ⁇ Test Example 5 Evaluation of phytotoxicity for growth inhibition against cucumber> The pot test evaluated the phytotoxicity of growth inhibition by foliar spray treatment.
  • a cucumber variety: SHARP1 cultivated using a square plastic pot (6 cm ⁇ 6 cm)
  • a compound (1) in the form of a wettable powder as in Formulation Example 1 was added with water at a predetermined concentration (1000 and 500 mg / day).
  • L was diluted and suspended and sprayed at a rate of 1000 L / ha.
  • the sprayed leaves were air-dried and managed in a greenhouse.
  • the second internode length of the cucumber was measured on the 11th day after the drug application.
  • the test was conducted using compound (9) and metconazole instead of compound (1) or without using any drug. The results are shown in Table 5.
  • Compound (1) was dissolved in dimethyl sulfoxide and added to PDA medium (potato-dextrose-aggar medium) at around 60 ° C. After mixing well in an Erlenmeyer flask, it was poured into a petri dish and solidified to prepare a plate medium containing the compound (1) at a predetermined concentration (5 mg / L).
  • PDA medium potato-dextrose-aggar medium
  • test bacteria Pyrenophora graminea, Sclerotinia sclerotiorum, or Botrytis cinerea
  • a cork borer with a diameter of 4 mm.
  • each fungus was cultured at an appropriate temperature for growth (for example, LIST OF CULTURES 1996 microorganisms 10th edition, refer to the literature of Foundation for Fermentation, etc.) for 1 to 14 days, and the growth of the fungus was measured by the fungus diameter.
  • the growth degree of the bacteria obtained on the drug-containing plate medium was compared with the growth degree of the bacteria in the drug-free group, and the mycelial elongation suppression rate was determined by the following formula.
  • R represents the hyphal elongation inhibition rate (%)
  • dc represents the diameter of the fungus on the untreated plate
  • dt represents the diameter of the fungus on the drug-treated plate.
  • R 100 (dc ⁇ dt) / dc
  • the mycelial elongation suppression rate R was 80% or more for all the bacteria.
  • the present invention can be suitably used as an active ingredient of a control agent that can minimize plant phytotoxicity and can control plant diseases.

Abstract

Provided is an azole derivative characterized by represented by general formula (I) or (Ia), for the purpose of providing a compound which has a high control effect on plant diseases and of which the toxic effect thereof can be reduced to a low level.

Description

アゾール誘導体、アゾール誘導体の製造方法、中間体化合物、ならびに農園芸用薬剤および工業用材料保護剤Azole derivatives, methods for producing azole derivatives, intermediate compounds, agricultural and horticultural agents and industrial material protecting agents
 新規なアゾール誘導体、ならびに当該アゾール誘導体の製造方法および中間体化合物に関する。また、当該アゾール誘導体を有効成分として含有する農園芸用薬剤および工業用材料保護剤に関する。 The present invention relates to a novel azole derivative, a method for producing the azole derivative, and an intermediate compound. Moreover, it is related with the agricultural and horticultural chemical | medical agent and industrial material protecting agent which contain the said azole derivative as an active ingredient.
 従来、植物病害防除剤の有効成分として多数のアゾリルメチルシクロペンタノール誘導体が開発されてきており、例えば、2-(ハロゲン化炭化水素置換)-5-ベンジル-1-アゾリルメチルシクロペンタノール誘導体(例えば、特許文献1参照)、5-メルカプト-[1,2,4]トリアゾリルメチル-シクロペンタノール誘導体(例えば、特許文献2~5参照)が開発されている。 Conventionally, a large number of azolylmethylcyclopentanol derivatives have been developed as active ingredients of plant disease control agents. For example, 2- (halogenated hydrocarbon substitution) -5-benzyl-1-azolylmethylcyclopentanol Derivatives (for example, see Patent Document 1) and 5-mercapto- [1,2,4] triazolylmethyl-cyclopentanol derivatives (for example, see Patent Documents 2 to 5) have been developed.
国際公開WO2011/070771号(2011年6月16日公開)International Publication WO2011 / 077071 (released on June 16, 2011) 国際公開WO2010/122167号(2010年10月28日公開)International Publication No. WO2010 / 122167 (released on October 28, 2010) 国際公開WO2010/122169号(2010年10月28日公開)International Publication No. WO2010 / 122169 (released on October 28, 2010) 国際公開WO2010/122170号(2010年10月28日公開)International Publication No. WO2010 / 122170 (October 28, 2010) 国際公開WO2010/149414号(2010年12月29日公開)International Publication WO2010 / 149414 (Released on December 29, 2010)
 安全性および防除効果に対する要望等に加えて、農園芸用薬剤には、植物に対する薬害の低減化も強く望まれている。 In addition to demands for safety and control effects, agricultural and horticultural drugs are also strongly desired to reduce phytotoxicity to plants.
 そこで、本発明は上記の問題点に鑑みてなされたものであり、その目的は、植物病害に対して高い防除効果を示すとともに、植物に対する薬害が低減している農園芸用薬剤において有効成分として含有されるアゾール誘導体を提供することにある。 Therefore, the present invention has been made in view of the above problems, and its purpose is to provide a high control effect against plant diseases, and as an active ingredient in agricultural and horticultural medicines with reduced phytotoxicity to plants. It is to provide an azole derivative to be contained.
 上記課題解決のため、本発明者らが鋭意検討した結果、下記一般式(I)で示されるアゾール誘導体および下記一般式(Ia)で示されるアゾール誘導体が優れた活性を有するとともに、植物に対する薬害が低減していることを見出し、本発明を完成させるにいたった。 As a result of intensive studies by the present inventors for solving the above-mentioned problems, the azole derivative represented by the following general formula (I) and the azole derivative represented by the following general formula (Ia) have excellent activity and phytotoxicity to plants. Has been found to be reduced, and the present invention has been completed.
 すなわち、本発明は、係る新規知見に基づいてなされたものであり、以下の発明を包含する。 That is, the present invention has been made on the basis of such novel findings, and includes the following inventions.
 下記一般式(I)または(Ia)で示されることを特徴とするアゾール誘導体。 An azole derivative characterized by being represented by the following general formula (I) or (Ia).
Figure JPOXMLDOC01-appb-C000009
Figure JPOXMLDOC01-appb-C000009
(一般式(I)および(Ia)中、Yは、ハロゲン原子を表し、
は、炭素数1~3のアルキル基、炭素数1~3のアルコキシ基または水素原子を表し、
は、ハロゲン原子を表し、mは、0、1または2を表し、mが2である場合には、複数あるYは互いに異なっていてもよく、
Aは、窒素原子またはメチン基を表す。
一般式(I)中、Xは、-SH、-SR、-SO-R、-SO-Rまたは-SOHを表す。Rは、炭素原子数1~6のアルキル基、炭素原子数2~6のアルケニル基、炭素原子数1~6のハロアルキル基、炭素原子数2~6のハロアルケニル基、アリール基またはアリールアルキル基(アルキル部分の炭素原子数が1~4)であり、Rにおける上記アリール基およびアリールアルキル基は、芳香環における少なくとも1つの水素原子がハロゲン原子、炭素数1~4のアルキル基(シクロアルキル基を含む)、または炭素数1~4のハロアルキル基で置換されていてもよい。)
 上述のアゾール誘導体を製造するために用いられる中間体化合物であって、下記一般式(II)または(IIa)で示される中間体化合物。
(In the general formulas (I) and (Ia), Y 1 represents a halogen atom,
R 1 represents an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, or a hydrogen atom,
Y 2 represents a halogen atom, m represents 0, 1 or 2, and when m is 2, a plurality of Y 2 may be different from each other;
A represents a nitrogen atom or a methine group.
In the general formula (I), X represents —SH, —SR 2 , —SO—R 2 , —SO 2 —R 2 or —SO 3 H. R 2 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a haloalkyl group having 1 to 6 carbon atoms, a haloalkenyl group having 2 to 6 carbon atoms, an aryl group, or an arylalkyl A group (the alkyl part has 1 to 4 carbon atoms), and in the aryl group and arylalkyl group in R 2 , at least one hydrogen atom in the aromatic ring is a halogen atom, and an alkyl group having 1 to 4 carbon atoms (cyclohexane). An alkyl group), or a haloalkyl group having 1 to 4 carbon atoms. )
An intermediate compound used for producing the above azole derivative, which is represented by the following general formula (II) or (IIa).
Figure JPOXMLDOC01-appb-C000010
Figure JPOXMLDOC01-appb-C000010
(一般式(II)および(IIa)中、R、Y、mおよびAは、それぞれ上記一般式(I)および(Ia)におけるR、Y、mおよびAと同じである。一般式(II)中、Xは、上記一般式(I)におけるXと同じである。)
 上述のアゾール誘導体の製造方法であって、下記一般式(II)または(IIa)で示される中間体化合物をハロゲン酸と反応させて、上記一般式(I)または(Ia)で示されるアゾール誘導体を得る工程を含むアゾール誘導体の製造方法。
(In the general formula (II) and (IIa), R 1, Y 2, m and A are the same as R 1, Y 2, m and A in each of the above general formula (I) and (Ia). General In the formula (II), X is the same as X in the general formula (I).)
A process for producing the above azole derivative, wherein an intermediate compound represented by the following general formula (II) or (IIa) is reacted with a halogen acid to produce an azole derivative represented by the above general formula (I) or (Ia) The manufacturing method of the azole derivative including the process of obtaining.
Figure JPOXMLDOC01-appb-C000011
Figure JPOXMLDOC01-appb-C000011
(一般式(II)および(IIa)中、R、Y、mおよびAは、それぞれ上記一般式(I)におけるR、Y、mおよびAと同じである。一般式(II)中、Xは、上記一般式(I)におけるXと同じである。)
 また、本発明は、上述のアゾール誘導体を有効成分として含有することを特徴とする農園芸用薬剤または工業用材料保護剤も包含する。
(In General Formulas (II) and (IIa), R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in General Formula (I), respectively. General Formula (II) In the formula, X is the same as X in the general formula (I).)
Moreover, this invention also includes the agricultural and horticultural chemical | medical agent or industrial material protecting agent characterized by containing the above-mentioned azole derivative as an active ingredient.
 本発明に係るアゾール誘導体は、植物に病害を引き起こす多くの菌に対して優れた殺菌作用を有するとともに、植物に対する薬害が低く抑えられている。したがって、本発明に係るアゾール誘導体を有効成分として含む薬剤は、広範な植物病害に対して高い防除効果を発揮するとともに、薬害を低く抑えることができる効果を奏する。 The azole derivative according to the present invention has an excellent bactericidal action against many bacteria that cause diseases on plants, and has low phytotoxicity on plants. Therefore, the chemical | medical agent which contains the azole derivative which concerns on this invention as an active ingredient has the effect which can suppress a chemical damage low while exhibiting the high control effect with respect to a wide range of plant diseases.
 以下、本発明に係るアゾール誘導体について説明する。 Hereinafter, the azole derivative according to the present invention will be described.
 〔アゾール誘導体〕
 本発明に係るアゾール誘導体は、下記一般式(I)または(Ia)で示されるアゾール誘導体である。以下、一般式(I)で示されるアゾール誘導体をアゾール誘導体(I)と称し、一般式(Ia)で示されるアゾール誘導体をアゾール誘導体(Ia)と称する。
[Azole derivatives]
The azole derivative according to the present invention is an azole derivative represented by the following general formula (I) or (Ia). Hereinafter, the azole derivative represented by the general formula (I) is referred to as an azole derivative (I), and the azole derivative represented by the general formula (Ia) is referred to as an azole derivative (Ia).
Figure JPOXMLDOC01-appb-C000012
Figure JPOXMLDOC01-appb-C000012
(一般式(I)および(Ia)中、Yは、ハロゲン原子を表し、
は、炭素数1~3のアルキル基、炭素数1~3のアルコキシ基または水素原子を表し、
は、ハロゲン原子を表し、mは、0、1または2を表し、mが2である場合には、複数あるYは互いに異なっていてもよく、
Aは、窒素原子またはメチン基を表す。
一般式(I)中、Xは、-SH、-SR、-SO-R、-SO-Rまたは-SOHを表す。Rは、炭素原子数1~6のアルキル基、炭素原子数2~6のアルケニル基、炭素原子数1~6のハロアルキル基、炭素原子数2~6のハロアルケニル基、アリール基またはアリールアルキル基(アルキル部分の炭素原子数が1~4)であり、Rにおける上記アリール基およびアリールアルキル基は、芳香環における少なくとも1つの水素原子がハロゲン原子、炭素数1~4のアルキル基(シクロアルキル基を含む)、または炭素数1~4のハロアルキル基で置換されていてもよい。)
 Yは、ハロゲン原子を表している。Yにおけるハロゲン原子としては、具体的には、フッ素原子、塩素原子、臭素原子およびヨウ素原子を挙げることができ、フッ素原子、塩素原子および臭素原子がより好ましく、塩素原子および臭素原子がさらに好ましく、塩素原子が特に好ましい。
(In the general formulas (I) and (Ia), Y 1 represents a halogen atom,
R 1 represents an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, or a hydrogen atom,
Y 2 represents a halogen atom, m represents 0, 1 or 2, and when m is 2, a plurality of Y 2 may be different from each other;
A represents a nitrogen atom or a methine group.
In the general formula (I), X represents —SH, —SR 2 , —SO—R 2 , —SO 2 —R 2 or —SO 3 H. R 2 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a haloalkyl group having 1 to 6 carbon atoms, a haloalkenyl group having 2 to 6 carbon atoms, an aryl group, or an arylalkyl A group (the alkyl part has 1 to 4 carbon atoms), and in the aryl group and arylalkyl group in R 2 , at least one hydrogen atom in the aromatic ring is a halogen atom, and an alkyl group having 1 to 4 carbon atoms (cyclohexane). An alkyl group), or a haloalkyl group having 1 to 4 carbon atoms. )
Y 1 represents a halogen atom. Specific examples of the halogen atom for Y 1 include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom, a fluorine atom, a chlorine atom and a bromine atom are more preferred, and a chlorine atom and a bromine atom are more preferred. A chlorine atom is particularly preferred.
 Rは、炭素数1~3のアルキル基、炭素数1~3のアルコキシ基または水素原子を表している。炭素数1~3のアルキル基としては、メチル基、エチル基、n-プロピル基、および1-メチルエチル基が挙げられる。炭素数1~3のアルコキシ基としては、メトキシ基、エトキシ基、n-プロポキシ基、および1-メチルエトキシ基が挙げられる。好ましくは、Rは水素原子である。 R 1 represents an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, or a hydrogen atom. Examples of the alkyl group having 1 to 3 carbon atoms include a methyl group, an ethyl group, an n-propyl group, and a 1-methylethyl group. Examples of the alkoxy group having 1 to 3 carbon atoms include a methoxy group, an ethoxy group, an n-propoxy group, and a 1-methylethoxy group. Preferably, R 1 is a hydrogen atom.
 Yは、ハロゲン原子を表している。ハロゲン原子としては、具体的には、フッ素原子、塩素原子、臭素原子およびヨウ素原子を挙げることができ、中でもフッ素原子、塩素原子および臭素原子がより好ましく、フッ素原子および塩素原子が特に好ましい。 Y 2 represents a halogen atom. Specific examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom, among which a fluorine atom, a chlorine atom and a bromine atom are more preferable, and a fluorine atom and a chlorine atom are particularly preferable.
 mは、0、1または2を表している。mが1または2である場合に、Yの結合位置は特に制限されるものではないが、mが1である場合には、4-置換ベンジル基となることが好ましい。また、mが2である場合には、2,4-置換ベンジル基となることが好ましい。mが2である場合には、複数あるYは互いに異なっていてもよいが、互いに同じであることがより好ましい。好ましくはmは0または1である。 m represents 0, 1 or 2. When m is 1 or 2, the bonding position of Y 2 is not particularly limited, but when m is 1, it is preferably a 4-substituted benzyl group. When m is 2, it is preferably a 2,4-substituted benzyl group. When m is 2, a plurality of Y 2 may be different from each other, but more preferably the same as each other. Preferably m is 0 or 1.
 Aは、窒素原子またはメチン基を表している。好ましくは、Aは窒素原子である。 A represents a nitrogen atom or a methine group. Preferably A is a nitrogen atom.
 Xは、-SH、-SR、-SO-R、-SO-Rまたは-SOHを表す。ここで、Rは、炭素数1~6のアルキル基、炭素数2~6のアルケニル基、炭素数1~6のハロアルキル基、炭素数2~6のハロアルケニル基、アリール基またはアリールアルキル基(アルキル部分の炭素数が1~4)を表している。 X represents —SH, —SR 2 , —SO—R 2 , —SO 2 —R 2 or —SO 3 H. R 2 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a haloalkyl group having 1 to 6 carbon atoms, a haloalkenyl group having 2 to 6 carbon atoms, an aryl group, or an arylalkyl group (Wherein the alkyl moiety has 1 to 4 carbon atoms).
 炭素数1~6のアルキル基としては、メチル基、エチル基、n-プロピル基、1-メチルエチル基、n-ブチル基、1-メチルプロピル基、2-メチルプロピル基、1,1-ジメチルエチル基、n-ペンチル基、1-メチルブチル基、2-メチルブチル基、3-メチルブチル基、1,1-ジメチルプロピル基、2,2-ジメチルプロピル基、1,2-ジメチルプロピル基、1-エチルプロピル基、n-ヘキシル基、1-メチルペンチル基、2-メチルペンチル基、3-メチルペンチル基、4-メチルペンチル基、1,1-ジメチルブチル基、1,2-ジメチルブチル基、1,3-ジメチルブチル基、2,2-ジメチルブチル基、2,3-ジメチルブチル基、3,3-ジメチルブチル基、1-エチルブチル基、2-エチルブチル基、1,1,2-トリメチルプロピル基、1,2,2-トリメチルプロピル基、1-エチル-1-メチルプロピル基および1-エチル-2-メチルプロピル基等が挙げられる。 Examples of the alkyl group having 1 to 6 carbon atoms include methyl group, ethyl group, n-propyl group, 1-methylethyl group, n-butyl group, 1-methylpropyl group, 2-methylpropyl group, 1,1-dimethyl group. Ethyl group, n-pentyl group, 1-methylbutyl group, 2-methylbutyl group, 3-methylbutyl group, 1,1-dimethylpropyl group, 2,2-dimethylpropyl group, 1,2-dimethylpropyl group, 1-ethyl Propyl group, n-hexyl group, 1-methylpentyl group, 2-methylpentyl group, 3-methylpentyl group, 4-methylpentyl group, 1,1-dimethylbutyl group, 1,2-dimethylbutyl group, 1, 3-dimethylbutyl group, 2,2-dimethylbutyl group, 2,3-dimethylbutyl group, 3,3-dimethylbutyl group, 1-ethylbutyl group, 2-ethylbutyl group, 1,1, - trimethylpropyl group, 1,2,2-trimethyl propyl group, a 1-ethyl-1-methylpropyl group and 1-ethyl-2-methylpropyl group.
 炭素数2~6のアルケニル基としては、エテニル基、1-プロペニル基、2-プロペニル基、1-メチルエテニル基、1-ブテニル基、2-ブテニル基、3-ブテニル基、1-メチル-1-プロペニル基、2-メチル-1-プロペニル基、1-メチル-2-プロペニル基、2-メチル-2-プロペニル基、1-ペンテニル基、2-ペンテニル基、3-ペンテニル基、4-ペンテニル基、1-メチル-1-ブテニル基、2-メチル-1-ブテニル基、3-メチル-1-ブテニル基、1-メチル-2-ブテニル基、2-メチル-2-ブテニル基、3-メチル-2-ブテニル基、1-メチル-3-ブテニル基、2-メチル-3-ブテニル基、3-メチル-3-ブテニル基、1,1-ジメチル-2-プロペニル基、1,2-ジメチル-1-プロペニル基、1,2-ジメチル-2-プロペニル基、1-エチル-1-プロペニル基、1-エチル-2-プロペニル基、1-ヘキセニル基、2-ヘキセニル基、3-ヘキセニル基、4-ヘキセニル基、5-ヘキセニル基、1-メチル-1-ペンテニル基、2-メチル-1-ペンテニル基、3-メチル-1-ペンテニル基、4-メチル-1-ペンテニル基、1-メチル-2-ペンテニル基、2-メチル-2-ペンテニル基、3-メチル-2-ペンテニル基、4-メチル-2-ペンテニル基、1-メチル-3-ペンテニル基、2-メチル-3-ペンテニル基、3-メチル-3-ペンテニル基、4-メチル-3-ペンテニル基、1-メチル-4-ペンテニル基、2-メチル-4-ペンテニル基、3-メチル-4-ペンテニル基、4-メチル-4-ペンテニル基、1,1-ジメチル-2-ブテニル基、1,1-ジメチル-3-ブテニル基、1,2-ジメチル-1-ブテニル基、1,2-ジメチル-2-ブテニル基、1,2-ジメチル-3-ブテニル基、1,3-ジメチル-1-ブテニル基、1,3-ジメチル-2-ブテニル基、1,3-ジメチル-3-ブテニル基、2,2-ジメチル-3-ブテニル基、2,3-ジメチル-1-ブテニル基、2,3-ジメチル-2-ブテニル基、2,3-ジメチル-3-ブテニル基、3,3-ジメチル-1-ブテニル基、1-エチル-1-ブテニル基、1-エチル-2-ブテニル基、1-エチル-3-ブテニル基、2-エチル-1-ブテニル基、2-エチル-2-ブテニル基、2-エチル-3-ブテニル基、1,1,2-トリメチル-2-プロペニル基、1-エチル-1-メチル-2-プロペニル基、1-エチル-2-メチル-1-プロペニル基および1-エチル-2-メチル-2-プロペニル基等が挙げられる。 Examples of the alkenyl group having 2 to 6 carbon atoms include ethenyl group, 1-propenyl group, 2-propenyl group, 1-methylethenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-1- Propenyl group, 2-methyl-1-propenyl group, 1-methyl-2-propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-1-butenyl group, 2-methyl-1-butenyl group, 3-methyl-1-butenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 3-methyl-2 -Butenyl group, 1-methyl-3-butenyl group, 2-methyl-3-butenyl group, 3-methyl-3-butenyl group, 1,1-dimethyl-2-propenyl group, 1,2-dimethyl-1- Propeni Group, 1,2-dimethyl-2-propenyl group, 1-ethyl-1-propenyl group, 1-ethyl-2-propenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group 5-hexenyl group, 1-methyl-1-pentenyl group, 2-methyl-1-pentenyl group, 3-methyl-1-pentenyl group, 4-methyl-1-pentenyl group, 1-methyl-2-pentenyl group 2-methyl-2-pentenyl group, 3-methyl-2-pentenyl group, 4-methyl-2-pentenyl group, 1-methyl-3-pentenyl group, 2-methyl-3-pentenyl group, 3-methyl- 3-pentenyl group, 4-methyl-3-pentenyl group, 1-methyl-4-pentenyl group, 2-methyl-4-pentenyl group, 3-methyl-4-pentenyl group, 4-methyl-4-pentenyl group 1,1-dimethyl-2-butenyl group, 1,1-dimethyl-3-butenyl group, 1,2-dimethyl-1-butenyl group, 1,2-dimethyl-2-butenyl group, 1,2- Dimethyl-3-butenyl group, 1,3-dimethyl-1-butenyl group, 1,3-dimethyl-2-butenyl group, 1,3-dimethyl-3-butenyl group, 2,2-dimethyl-3-butenyl group 2,3-dimethyl-1-butenyl group, 2,3-dimethyl-2-butenyl group, 2,3-dimethyl-3-butenyl group, 3,3-dimethyl-1-butenyl group, 1-ethyl-1 -Butenyl group, 1-ethyl-2-butenyl group, 1-ethyl-3-butenyl group, 2-ethyl-1-butenyl group, 2-ethyl-2-butenyl group, 2-ethyl-3-butenyl group, 1 , 1,2-Trimethyl-2-propenyl group, 1-ethyl Examples include a 1-methyl-2-propenyl group, a 1-ethyl-2-methyl-1-propenyl group, and a 1-ethyl-2-methyl-2-propenyl group.
 炭素数1~6のハロアルキル基としては、クロロメチル基、ブロモメチル基、ジクロロメチル基、トリクロロメチル基、フルオロメチル基、ジフルオロメチル基、トリフルオロメチル基、クロロフルオロメチル基、ジクロロフルオロメチル基、クロロジフルオロメチル基、1-クロロエチル基、1-ブロモエチル基、1-フルオロエチル基、2-フルオロエチル基、2,2-ジフルオロエチル基、2,2,2-トリフルオロエチル基、2-クロロ-2-フルオロエチル基、2-クロロ-2,2-ジフルオロエチル基、2,2-ジクロロ-2-フルオロエチル基、2,2,2-トリクロロエチル基およびペンタフルオロエチル基等が挙げられる。 Examples of the haloalkyl group having 1 to 6 carbon atoms include chloromethyl group, bromomethyl group, dichloromethyl group, trichloromethyl group, fluoromethyl group, difluoromethyl group, trifluoromethyl group, chlorofluoromethyl group, dichlorofluoromethyl group, chloro Difluoromethyl group, 1-chloroethyl group, 1-bromoethyl group, 1-fluoroethyl group, 2-fluoroethyl group, 2,2-difluoroethyl group, 2,2,2-trifluoroethyl group, 2-chloro-2 -Fluoroethyl group, 2-chloro-2,2-difluoroethyl group, 2,2-dichloro-2-fluoroethyl group, 2,2,2-trichloroethyl group, pentafluoroethyl group and the like.
 炭素数2~6のハロアルケニル基としては、2-クロロエテニル基、2,2-ジクロロエテニル基、2-クロロ-2-プロペニル基、3,3-ジクロロ-2-プロペニル基、2,3-ジクロロ-2-プロペニル基、3,3-ジクロロ-2-メチル-2-プロペニル基、3-クロロ-2-ブテニル基、2-フルオロエテニル基、2,2-ジフルオロエテニル基、2-フルオロ-2-プロペニル基、3,3-ジフルオロ-2-プロペニル基、2,3-ジフルオロ-2-プロペニル基、3,3-ジフルオロ-2-メチル-2-プロペニル基、3-フルオロ-2-ブテニル基、2-ブロモエテニル基、2,2-ジブロモエテニル基、2-ブロモ-2-プロペニル基、3,3-ジブロモ-2-プロペニル基、2,3-ジブロモ-2-プロペニル基、3,3-ジブロモ-2-メチル-2-プロペニル基、3-ブロモ-2-ブテニル基、2-ヨードエテニル基、2,2-ジヨードエテニル基、2-ヨード-2-プロペニル基、3,3-ジヨード-2-プロペニル基および2,3-ジヨード-2-プロペニル基等が挙げられる。 Examples of the haloalkenyl group having 2 to 6 carbon atoms include 2-chloroethenyl group, 2,2-dichloroethenyl group, 2-chloro-2-propenyl group, 3,3-dichloro-2-propenyl group, 2,3-dichloro -2-propenyl group, 3,3-dichloro-2-methyl-2-propenyl group, 3-chloro-2-butenyl group, 2-fluoroethenyl group, 2,2-difluoroethenyl group, 2-fluoro- 2-propenyl group, 3,3-difluoro-2-propenyl group, 2,3-difluoro-2-propenyl group, 3,3-difluoro-2-methyl-2-propenyl group, 3-fluoro-2-butenyl group 2-bromoethenyl group, 2,2-dibromoethenyl group, 2-bromo-2-propenyl group, 3,3-dibromo-2-propenyl group, 2,3-dibromo-2-propenyl group, 3 3-dibromo-2-methyl-2-propenyl group, 3-bromo-2-butenyl group, 2-iodoethenyl group, 2,2-diiodoethenyl group, 2-iodo-2-propenyl group, 3,3-diiodo-2 -Propenyl group, 2,3-diiodo-2-propenyl group and the like.
 アリールアルキル基(アルキル部分の炭素数が1~4)としては、フェニルメチル基、フェニルナフチル基、1-フェニルエチル基、2-フェニルエチル基、2-ナフチルエチル基、1-フェニルプロピル基、2-フェニルプロピル基、3-フェニルプロピル基、1-メチル-2-フェニルエチル基、1-メチル-1-フェニルエチル基および4-フェニルブチル基等が挙げられる。 As the arylalkyl group (the alkyl part has 1 to 4 carbon atoms), phenylmethyl group, phenylnaphthyl group, 1-phenylethyl group, 2-phenylethyl group, 2-naphthylethyl group, 1-phenylpropyl group, 2 -Phenylpropyl group, 3-phenylpropyl group, 1-methyl-2-phenylethyl group, 1-methyl-1-phenylethyl group, 4-phenylbutyl group and the like can be mentioned.
 アリール基としては、フェニル基、ナフチル基、ビフェニル基、アントリル基およびフェナントリル基等が挙げられる。 Examples of the aryl group include a phenyl group, a naphthyl group, a biphenyl group, an anthryl group, and a phenanthryl group.
 Rにおけるアリール基およびアリールアルキル基の芳香環における水素原子の1つ、2つまたは3つは、ハロゲン原子、炭素数1~4のアルキル基(シクロアルキル基を含む)、または炭素数1~4のハロアルキル基で置換されていてもよい。 One, two or three of the hydrogen atoms in the aromatic ring of the aryl group and arylalkyl group for R 2 are a halogen atom, an alkyl group having 1 to 4 carbon atoms (including a cycloalkyl group), or 1 to It may be substituted with 4 haloalkyl groups.
 Rにおけるアリール基およびアリールアルキル基の芳香環における置換基としてのハロゲン原子としては、フッ素原子、塩素原子、臭素原子およびヨウ素原子が挙げられる。同様に置換基としての炭素数1~4のアルキル基としては、メチル基、エチル基、n-プロピル基、1-メチルエチル基、n-ブチル基、1-メチルプロピル基、2-メチルプロピル基、1,1-ジメチルエチル基およびシクロプロピルメチル基等が挙げられる。同様に置換基としての炭素数1~4のハロアルキル基としては、トリフルオロメチル基、ペンタフルオロエチル基、クロロメチル基、トリクロロメチル基およびブロモメチル基等が挙げられる。より好ましくは、フッ素原子、塩素原子、臭素原子、メチル基、エチル基、トリフルオロメチル基およびクロロメチル基である。 Examples of the halogen atom as a substituent in the aromatic ring of the aryl group and arylalkyl group in R 2 include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. Similarly, the alkyl group having 1 to 4 carbon atoms as a substituent includes a methyl group, an ethyl group, an n-propyl group, a 1-methylethyl group, an n-butyl group, a 1-methylpropyl group, and a 2-methylpropyl group. 1,1-dimethylethyl group, cyclopropylmethyl group and the like. Similarly, examples of the haloalkyl group having 1 to 4 carbon atoms as a substituent include a trifluoromethyl group, a pentafluoroethyl group, a chloromethyl group, a trichloromethyl group, and a bromomethyl group. More preferred are fluorine atom, chlorine atom, bromine atom, methyl group, ethyl group, trifluoromethyl group and chloromethyl group.
 なお、アゾール誘導体(Ia)は、一般式(I)におけるXが-SHである下記一般式(Ib)で示されるアゾール誘導体(「メルカプト」形)の互変異性形(「チオノ」形)である。 The azole derivative (Ia) is a tautomeric form (“thiono” form) of an azole derivative (“mercapto” form) represented by the following general formula (Ib) in which X in the general formula (I) is —SH. is there.
Figure JPOXMLDOC01-appb-C000013
Figure JPOXMLDOC01-appb-C000013
(一般式(Ib)中、R、Y、Y、mおよびAは、それぞれ上記一般式(I)におけるR、Y、Y、mおよびAと同じである。)
 アゾール誘導体(I)または(Ia)を農園芸用薬剤あるいは工業用材料保護剤の有効成分として用いた場合、植物体内および細菌の細胞内では、トリアゾール環あるいはイミダゾール環における官能基-Xまたは=Sが脱離することにより、その活性を発現する。
(In the general formula (Ib), R 1, Y 1, Y 2, m and A are each the same as R 1, Y 1, Y 2 , m and A in the general formula (I).)
When the azole derivative (I) or (Ia) is used as an active ingredient of an agricultural or horticultural agent or an industrial material protecting agent, in a plant body or bacterial cell, a functional group -X or = S in the triazole ring or imidazole ring Is released, and its activity is expressed.
 本発明に係るアゾール誘導体の好ましい具体例としては、例えば、下記一般式(Ic)または(Id)で示されるアゾール誘導体を挙げることができるが、これに限定されるものではない。 Specific examples of preferred azole derivatives according to the present invention include, but are not limited to, azole derivatives represented by the following general formula (Ic) or (Id).
Figure JPOXMLDOC01-appb-C000014
Figure JPOXMLDOC01-appb-C000014
(一般式(Ic)および(Id)中、R、Y、YおよびAは、それぞれ上記一般式(I)および(Ia)におけるR、Y、YおよびAと同じである。一般式(Ic)中、Xは、上記一般式(I)におけるXと同じである。)
 さらに、本発明に係るアゾール誘導体のより好ましい具体例としては、例えば、下記一般式(Ie)で示されるアゾール誘導体を挙げることができる。
(In the general formula (Ic) and (Id), R 1, Y 1, Y 2 and A are the same as R 1, Y 1, Y 2 and A in each of the above general formula (I) and (Ia) In general formula (Ic), X is the same as X in general formula (I) above.)
Furthermore, specific examples of the azole derivative according to the present invention include azole derivatives represented by the following general formula (Ie).
Figure JPOXMLDOC01-appb-C000015
Figure JPOXMLDOC01-appb-C000015
(一般式(Ie)中、Yは、水素原子、フッ素原子または塩素原子を表す。)
 なお、アゾール誘導体(I)および(Ia)には、シクロペンタン環に結合している有機基の立体配置に基づく立体異性体が存在し、立体異性体毎に光学異性体が存在する。したがって、アゾール誘導体(I)および(Ia)は、これら異性体を単独で含むもの、および、各異性体を任意の比率で含むもののいずれをも含むものである。中でも、シクロペンタン環に結合しているヒドロキシ基とハロメチル基とがシス型であるアゾール誘導体が好ましく、シクロペンタン環に結合しているヒドロキシ基とハロメチル基と置換または無置換のベンジル基とがシス型であるアゾール誘導体がより好ましい。
(In the general formula (Ie), Y 3 represents a hydrogen atom, a fluorine atom or a chlorine atom.)
In the azole derivatives (I) and (Ia), there are stereoisomers based on the configuration of the organic group bonded to the cyclopentane ring, and optical isomers exist for each stereoisomer. Therefore, the azole derivatives (I) and (Ia) include both those containing these isomers alone and those containing each isomer in an arbitrary ratio. Among them, an azole derivative in which a hydroxy group bonded to a cyclopentane ring and a halomethyl group are in cis form is preferable, and a hydroxy group bonded to a cyclopentane ring and a halomethyl group and a substituted or unsubstituted benzyl group are in cis form. An azole derivative which is a type is more preferable.
 〔2.アゾール誘導体の製造方法〕
 アゾール誘導体(I)および(Ia)の製造方法は、特に制限されるものではないが、例えば、下記一般式(III)で示されるアゾール誘導体(以下、アゾール誘導体(III)と称する)を出発原料として製造することができる。アゾール誘導体(III)の製造方法については後述する。
[2. Method for producing azole derivative]
The production method of the azole derivatives (I) and (Ia) is not particularly limited. For example, an azole derivative represented by the following general formula (III) (hereinafter referred to as azole derivative (III)) is a starting material. Can be manufactured as. A method for producing the azole derivative (III) will be described later.
Figure JPOXMLDOC01-appb-C000016
Figure JPOXMLDOC01-appb-C000016
(一般式(III)中、R、Y、mおよびAは、それぞれ上記一般式(I)におけるR、Y、mおよびAと同じである。)
 具体的には、アゾール誘導体(III)を希釈剤の存在下で順次強塩基および硫黄と反応させ、次いで生成物を水で加水分解する方法(反応(a))、あるいはアゾール誘導体(III)を硫黄粉末およびジメチルホルムアミドの存在下で反応させる方法(反応(b))により、下記一般式(IIa)で示されるアゾール誘導体(以下、アゾール誘導体(IIa)と称する)、あるいは下記一般式(IIb)で示されるアゾール誘導体(以下、アゾール誘導体(IIb)と称する)を得る。
(In general formula (III), R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in general formula (I), respectively.)
Specifically, a method in which the azole derivative (III) is successively reacted with a strong base and sulfur in the presence of a diluent and then the product is hydrolyzed with water (reaction (a)), or the azole derivative (III) is used. Depending on the method of reacting in the presence of sulfur powder and dimethylformamide (reaction (b)), an azole derivative represented by the following general formula (IIa) (hereinafter referred to as azole derivative (IIa)), or the following general formula (IIb) Is obtained (hereinafter referred to as azole derivative (IIb)).
Figure JPOXMLDOC01-appb-C000017
Figure JPOXMLDOC01-appb-C000017
(一般式(IIa)および(IIb)中、R、Y、mおよびAは、それぞれ上記一般式(I)におけるR、Y、mおよびAと同じである。)
次いで、得られたアゾール誘導体(IIa)あるいはアゾール誘導体(IIb)のオキセタン環を開環することにより、アゾール誘導体(Ia)、あるいは上記一般式(Ib)で示されるアゾール誘導体(以下、アゾール誘導体(Ib)と称する)を得ることができる。
(In the general formulas (IIa) and (IIb), R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in the general formula (I), respectively.)
Next, by opening the oxetane ring of the obtained azole derivative (IIa) or azole derivative (IIb), the azole derivative (Ia) or an azole derivative represented by the above general formula (Ib) (hereinafter referred to as azole derivative ( Ib)) can be obtained.
 なお、実際には、各工程においては、チオノ型であるアゾール誘導体(IIa)およびアゾール誘導体(Ia)が単離されるため、以下では、反応スキーム1に示すように、反応(a)および反応(b)を、アゾール誘導体(IIa)の製造方法として説明し、オキセタン環の開環反応を、アゾール誘導体(IIa)からアゾール誘導体(Ia)を製造する方法として説明する。 In fact, in each step, the azole derivative (IIa) and the azole derivative (Ia) which are thiono forms are isolated. Therefore, in the following, as shown in Reaction Scheme 1, reaction (a) and reaction ( b) will be described as a method for producing the azole derivative (IIa), and the oxetane ring opening reaction will be described as a method for producing the azole derivative (Ia) from the azole derivative (IIa).
Figure JPOXMLDOC01-appb-C000018
Figure JPOXMLDOC01-appb-C000018
(反応(a))
 反応(a)では、アゾール誘導体(III)を希釈剤の存在下で順次強塩基および硫黄と反応させ、次いで生成物を水で加水分解することにより、アゾール誘導体(IIa)を得る。
(Reaction (a))
In the reaction (a), the azole derivative (IIIa) is obtained by sequentially reacting the azole derivative (III) with a strong base and sulfur in the presence of a diluent, and then hydrolyzing the product with water.
 強塩基としては、類似の反応に一般的に使用される全ての強アルカリ金属塩基を挙げることができ、例えば、n-ブチルリチウム、リチウムジイソプロピルアミド、水素化ナトリウムおよびナトリウムアミド、ならびにテトラメチルエチレンジアミン(TMEDA)との混合物としてのカリウムt-ブトキシドを好適に使用できる。 Strong bases can include all strong alkali metal bases commonly used in similar reactions, such as n-butyllithium, lithium diisopropylamide, sodium hydride and sodium amide, and tetramethylethylenediamine ( Potassium t-butoxide as a mixture with TMEDA) can preferably be used.
 希釈剤としては、類似の反応に一般的に使用される全ての不活性有機溶媒を挙げることができ、例えば、テトラヒドロフラン(THF)、ジオキサン、ジエチルエーテルおよび1,2-ジメトキシエタン等のエーテル類、ならびに、液体アンモニアまたはジメチルスルホキシド等の強い極性溶媒を好適に使用できる。 Diluents can include all inert organic solvents commonly used in similar reactions, such as ethers such as tetrahydrofuran (THF), dioxane, diethyl ether and 1,2-dimethoxyethane, In addition, a strong polar solvent such as liquid ammonia or dimethyl sulfoxide can be preferably used.
 硫黄の使用量は、アゾール誘導体(III)1molに対し、例えば、硫黄1~5molであり、好適には硫黄1~1.5molである。硫黄は粉末の状態で用いることが好ましい。 The amount of sulfur used is, for example, 1 to 5 mol of sulfur, and preferably 1 to 1.5 mol of sulfur with respect to 1 mol of azole derivative (III). Sulfur is preferably used in a powder state.
 反応(a)における加水分解は酸の存在下で行われてもよく、当該酸としては、類似の反応に一般的に使用される全ての無機または有機酸を挙げることができ、例えば、酢酸、希硫酸および希塩酸を好適に使用し得る。しかしながらまた、加水分解は塩化アンモニウム水溶液を用いても行い得る。 Hydrolysis in reaction (a) may be carried out in the presence of an acid, which can include all inorganic or organic acids commonly used in similar reactions, such as acetic acid, Dilute sulfuric acid and dilute hydrochloric acid can be preferably used. However, the hydrolysis can also be carried out using an aqueous ammonium chloride solution.
 反応(a)における反応温度は、例えば、-70℃~20℃であり、好ましくは-70℃~0℃である。 The reaction temperature in the reaction (a) is, for example, −70 ° C. to 20 ° C., preferably −70 ° C. to 0 ° C.
 生成されるアゾール誘導体(IIa)は、慣用の方法、例えば再結晶およびクロマトグラフィー等によって分離および精製すればよい。 The produced azole derivative (IIa) may be separated and purified by a conventional method such as recrystallization and chromatography.
 (反応(b))
 反応(b)では、アゾール誘導体(III)を硫黄粉末およびジメチルホルムアミドの存在下で反応させることにより、アゾール誘導体(IIa)を得る。
(Reaction (b))
In the reaction (b), the azole derivative (IIa) is obtained by reacting the azole derivative (III) in the presence of sulfur powder and dimethylformamide.
 反応(b)によりアゾール誘導体(IIa)を製造する場合、アゾール誘導体(III)を希釈剤に希釈しておくことができる。希釈剤としては、すべての慣用の非プロトン性極性有機溶媒が利用可能である。好適には、ジメチルホルムアミド等のアミド類;N-オクチル-ピロリドンおよびN-ドデシル-ピロリドン等のN-アルキル-ピロリドン類;ならびにN-メチル-カプロラクタムおよびN-オクチル-カプロラクタム等のN-アルキル-カプロラクタム類が挙げられる。 When the azole derivative (IIa) is produced by the reaction (b), the azole derivative (III) can be diluted with a diluent. Any conventional aprotic polar organic solvent can be used as the diluent. Preferably, amides such as dimethylformamide; N-alkyl-pyrrolidones such as N-octyl-pyrrolidone and N-dodecyl-pyrrolidone; and N-alkyl-caprolactams such as N-methyl-caprolactam and N-octyl-caprolactam Kind.
 反応温度は、一定の範囲内で変えることができ、例えば、温度140℃~200℃であり、好適には150℃~160℃である。大気圧下または加圧下で反応を行うことができる。 The reaction temperature can be varied within a certain range, for example, a temperature of 140 ° C. to 200 ° C., preferably 150 ° C. to 160 ° C. The reaction can be carried out at atmospheric pressure or under pressure.
 硫黄の使用量は、アゾール誘導体(III)1molに対し、例えば、硫黄6~15molであり、好適には硫黄8~13molである。 The amount of sulfur used is, for example, 6 to 15 mol of sulfur, and preferably 8 to 13 mol of sulfur with respect to 1 mol of azole derivative (III).
 生成されるアゾール誘導体(IIa)は、慣用の方法、例えば再結晶およびクロマトグラフィー等によりによって分離および精製すればよい。 The azole derivative (IIa) produced may be separated and purified by a conventional method such as recrystallization and chromatography.
 (開環反応)
 次いで、アゾール誘導体(IIa)の有するオキセタン環を開環することにより、アゾール誘導体(Ia)を得る。オキセタン環を開環する方法としては、アゾール誘導体(IIa)とハロゲン酸とを溶媒中で混合し、ハロゲン化メチル基と3級ヒドロキシ基とを生成する方法が好適に用いられる。
(Ring-opening reaction)
Next, by opening the oxetane ring of the azole derivative (IIa), the azole derivative (Ia) is obtained. As a method for opening the oxetane ring, a method in which an azole derivative (IIa) and a halogen acid are mixed in a solvent to generate a halogenated methyl group and a tertiary hydroxy group is preferably used.
 ハロゲン酸としては、フッ化水素、塩化水素、臭化水素およびヨウ化水素を挙げることができる。中でも塩化水素および臭化水素が好適に用いられる。ハロゲン酸は、気体として導入してもよいし、有機溶媒に溶解させて添加してもよい。なお、ハロゲン化物塩(例えば、塩化リチウム、および塩化ナトリウム)と別種の酸(例えばトルエンスルホン酸、メタンスルホン酸および硫酸等のブレンステッド酸、または塩化アルミニウム等のルイス酸)とを添加することにより系内においてハロゲン酸を生成させて、アゾール誘導体(IIa)からアゾール誘導体(Ia)を得るようにしてもよい。 Examples of the halogen acid include hydrogen fluoride, hydrogen chloride, hydrogen bromide, and hydrogen iodide. Of these, hydrogen chloride and hydrogen bromide are preferably used. The halogen acid may be introduced as a gas, or may be added after being dissolved in an organic solvent. By adding a halide salt (for example, lithium chloride and sodium chloride) and another acid (for example, Bronsted acid such as toluenesulfonic acid, methanesulfonic acid and sulfuric acid, or Lewis acid such as aluminum chloride). The azole derivative (Ia) may be obtained from the azole derivative (IIa) by generating a halogen acid in the system.
 溶媒は、特に限定されないが、例えば、N-メチルピロリドンおよびN,N-ジメチルホルムアミド等のアミド類、メタノールおよびエタノールなどのアルコール類、テトラヒドロフランおよびジオキサン等のエーテル類、ならびに水を挙げることができる。中でも、ジメチルホルムアミド、メタノール、水およびジオキサンが好適に用いられる。 The solvent is not particularly limited, and examples thereof include amides such as N-methylpyrrolidone and N, N-dimethylformamide, alcohols such as methanol and ethanol, ethers such as tetrahydrofuran and dioxane, and water. Of these, dimethylformamide, methanol, water and dioxane are preferably used.
 ハロゲン酸の量は、アゾール誘導体(IIa)に対して、例えば、0.5倍モル~50倍モルであり、好適には、1倍モル~20倍モルである。 The amount of the halogen acid is, for example, 0.5 to 50 times mol, preferably 1 to 20 times mol with respect to the azole derivative (IIa).
 反応温度は、用いられる溶媒等によって適宜設定することができるが、例えば、-20℃~250℃であり、好適には-10℃~150℃であり、50℃~80℃であることが特に好ましい。反応時間は、用いられる溶媒等によって適宜設定することができるが、例えば、0.1時間~数日であり、好適には、1時間~48時間である。 The reaction temperature can be appropriately set depending on the solvent used and the like, and is, for example, −20 ° C. to 250 ° C., preferably −10 ° C. to 150 ° C., particularly 50 ° C. to 80 ° C. preferable. The reaction time can be appropriately set depending on the solvent used and the like. For example, the reaction time is 0.1 hour to several days, and preferably 1 hour to 48 hours.
 オキセタンにハロゲン酸が付加する場合、1位が3級ヒドロキシ基となり、2位がハロゲン化メチル基となる。 When halogen acid is added to oxetane, the 1-position becomes a tertiary hydroxy group and the 2-position becomes a halogenated methyl group.
 なお、本開環反応を含むアゾール誘導体(Ia)の製造方法によれば、シクロペンタン環に結合しているヒドロキシ基とハロメチル基とがシス型である幾何異性体のみを得ることができる。 In addition, according to the manufacturing method of azole derivative (Ia) including this ring-opening reaction, only the geometric isomer in which the hydroxy group and halomethyl group which are couple | bonded with the cyclopentane ring can be obtained.
 アゾール誘導体(Ib)以外の他のアゾール誘導体(I)については、アゾール誘導体(IIa)あるいはアゾール誘導体(IIb)から、下記の反応(c)、(d)または(e)により、下記一般式(IIc)で示されるアゾール誘導体(以下、アゾール誘導体(IIc)と称する)を合成し、アゾール誘導体(IIc)にハロゲン酸を反応させてアゾール誘導体(IIc)のオキセタン環を開環することにより、アゾール誘導体(Ib)以外の他のアゾール誘導体(I)を得ることができる。 Regarding the azole derivative (I) other than the azole derivative (Ib), the following general formula (I) can be obtained from the azole derivative (IIa) or azole derivative (IIb) by the following reaction (c), (d) or (e). IIc) is synthesized (hereinafter referred to as azole derivative (IIc)), and the azole derivative (IIc) is reacted with a halogen acid to open the oxetane ring of the azole derivative (IIc). Other azole derivatives (I) other than the derivative (Ib) can be obtained.
Figure JPOXMLDOC01-appb-C000019
Figure JPOXMLDOC01-appb-C000019
(一般式(IIc)中、R、Y、mおよびAは、それぞれ上記一般式(I)におけるR、Y、mおよびAと同じであり、Xは-SR、-SO-R、-SO-Rまたは-SOHを表し、Rは、上記一般式(I)におけるRと同じである。)
 以下、アゾール誘導体(IIa)用いた場合の反応(c)、(d)および(e)について説明する。なお、反応(c)、(d)または(e)後の開環反応は、アゾール誘導体(Ia)を得る際の開環反応と同様であるため、上述した説明を援用できる。
(In the general formula (IIc), R 1, Y 2, m and A are each the same as R 1, Y 2, m and A in the general formula (I), X 1 is -SR 2, -SO -R 2 , -SO 2 -R 2 or -SO 3 H is represented, and R 2 is the same as R 2 in the general formula (I).
Hereinafter, the reactions (c), (d), and (e) when the azole derivative (IIa) is used will be described. In addition, since the ring-opening reaction after reaction (c), (d) or (e) is the same as the ring-opening reaction at the time of obtaining azole derivative (Ia), description mentioned above can be used.
 (反応(c))
 反応(c)では、アゾール誘導体(IIa)を酸結合剤および希釈剤の存在下で、一般式(IV)
-L  ・・(IV)
(一般式(IV)中、Rは、炭素原子数1~6のアルキル基、炭素原子数2~6のアルケニル基、炭素原子数1~6のハロアルキル基、炭素原子数2~6のハロアルケニル基、アリールアルキル基(アルキル部分の炭素原子数が1~4)を表す。Lは、ハロゲン原子を表す。)
で示されるハロゲン化物と反応させことにより、Xが-SR(ただし、Rは、炭素原子数1~6のアルキル基、炭素原子数2~6のアルケニル基、炭素原子数1~6のハロアルキル基、炭素原子数2~6のハロアルケニル基またはアリールアルキル基(アルキル部分の炭素原子数が1~4)を表す)であるアゾール誘導体(IIc)を得る。
(Reaction (c))
In reaction (c), the azole derivative (IIa) is converted to a compound of the general formula (IV) in the presence of an acid binder and a diluent.
R 3 -L .. (IV)
(In the general formula (IV), R 3 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a haloalkyl group having 1 to 6 carbon atoms, or a halo having 2 to 6 carbon atoms. An alkenyl group or an arylalkyl group (the alkyl moiety has 1 to 4 carbon atoms). L represents a halogen atom.)
X 1 is —SR 2 (wherein R 2 is an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, or 1 to 6 carbon atoms). An azole derivative (IIc) is obtained, which is a haloalkyl group, a haloalkenyl group having 2 to 6 carbon atoms, or an arylalkyl group (wherein the alkyl moiety has 1 to 4 carbon atoms).
 Rにおける炭素原子数1~6のアルキル基、炭素原子数2~6のアルケニル基、炭素原子数1~6のハロアルキル基、炭素原子数2~6のハロアルケニル基、アリールアルキル基(アルキル部分の炭素原子数が1~4)は、Rにおけるこれらの基と同義である。 R 3 alkyl group having 1 to 6 carbon atoms, alkenyl group having 2 to 6 carbon atoms, haloalkyl group having 1 to 6 carbon atoms, haloalkenyl group having 2 to 6 carbon atoms, arylalkyl group (alkyl moiety) 1 to 4) has the same meaning as those of R 2 .
 Lは、ハロゲン原子を表しており、フッ素原子、塩素原子、臭素原子およびヨウ素原子を挙げることができる。 L represents a halogen atom, and examples thereof include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom.
 酸結合剤としては、一般的に使用される全ての無機塩基および有機塩基を挙げることでき、例えば、水酸化ナトリウム、水酸化カルシウムおよび水酸化カリウム等のアルカリ金属水酸化物またはアルカリ土類金属水酸化物;水酸化アンモニウム;炭酸ナトリウム、炭酸カリウム、炭酸水素カリウム、炭酸水素ナトリウム等のアルカリ金属炭酸塩;酢酸ナトリウム、酢酸カリウムおよび酢酸カルシウム等のアルカリ金属酢酸塩またはアルカリ土類金属酢酸塩;並びにトリメチルアミン、トリエチルアミン、トリブチルアミン、N,N-ジメチルアニリン、ピリジン、N-メチル-ピペリジン、N,N-ジメチルアミノピリジン、ジアザビシクロオクタン(DABCO)、ジアザビシクロノネン(DBN)およびジアザビシクロウンデセン(DBU)等の第三級アミンが好適に使用され得る。 Examples of acid binders include all commonly used inorganic bases and organic bases, such as alkali metal hydroxides or alkaline earth metal waters such as sodium hydroxide, calcium hydroxide and potassium hydroxide. Oxides; ammonium hydroxide; alkali metal carbonates such as sodium carbonate, potassium carbonate, potassium hydrogen carbonate, sodium hydrogen carbonate; alkali metal acetates or alkaline earth metal acetates such as sodium acetate, potassium acetate and calcium acetate; and Trimethylamine, triethylamine, tributylamine, N, N-dimethylaniline, pyridine, N-methyl-piperidine, N, N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) and diazabicycloun Decene (DB Tertiary amines such as U) can be suitably used.
 希釈剤としては、一般的に使用される全ての有機溶媒を挙げることができ、例えば、ジエチルエーテル、メチルt-ブチルエーテル、エチレングリコールジメチルエーテル、テトラヒドロフランおよびジオキサン等のエーテル類、アセトニトリル等のニトリル類、ならびにジメチルスルホキシドまたはジメチルホルムアミド等の極性溶媒を好適に使用し得る。 Diluents can include all commonly used organic solvents such as diethyl ether, methyl t-butyl ether, ethylene glycol dimethyl ether, ethers such as tetrahydrofuran and dioxane, nitriles such as acetonitrile, and the like. A polar solvent such as dimethyl sulfoxide or dimethylformamide can be suitably used.
 反応温度は、例えば、0℃~120℃であり、好ましくは20℃~100℃である。 The reaction temperature is, for example, 0 ° C. to 120 ° C., preferably 20 ° C. to 100 ° C.
 一般式(IV)で示されるハロゲン化物の使用量は、アゾール誘導体(IIa)1molに対し、例えば、1~2molである。酸結合剤は、例えば、アゾール誘導体(IIa)と等価量または過剰量を用いることができる。 The amount of the halide represented by the general formula (IV) is, for example, 1 to 2 mol with respect to 1 mol of the azole derivative (IIa). As the acid binder, for example, an equivalent amount or an excess amount of the azole derivative (IIa) can be used.
 (反応(d))
 反応(d)では、得られたアゾール誘導体(IIa)を、希釈剤の存在下で順次強塩基および一般式(V)
-S-S-R  (V)
(一般式(V)中、Rは、アリール基を表す。)
で示される化合物と反応させることにより、Xが-SR(ただし、Rは、アリール基を表す)であるアゾール誘導体(IIc)を得る。
(Reaction (d))
In the reaction (d), the azole derivative (IIa) obtained is sequentially converted into a strong base and a compound represented by the general formula (V)
R 4 —S—S—R 4 (V)
(In general formula (V), R 4 represents an aryl group.)
To obtain an azole derivative (IIc) in which X 1 is —SR 2 (where R 2 represents an aryl group).
 Rにおけるアリール基は、上記したRにおけるアリール基と同義である。 The aryl group in R 4 has the same meaning as the aryl group in R 2 described above.
 強塩基および希釈剤は、それぞれ反応(a)の説明に例示した強塩基および希釈剤を用いることができる。 As the strong base and diluent, the strong base and diluent exemplified in the description of the reaction (a) can be used.
 (反応(e))
 反応(e)では、アゾール誘導体(IIa)を酸化剤および希釈剤の存在下で反応させることにより、Xが-SOH、-SOまたは-SORであるアゾール誘導体(IIc)を得る。なお、反応(e)においては、アゾール誘導体(IIa)の代わりに、Xが-SRであるアゾール誘導体(IIc)を用いることができる。
(Reaction (e))
In reaction (e), azole derivative (IIc) in which X 1 is —SO 3 H, —SO 2 R 2 or —SOR 2 is obtained by reacting azole derivative (IIa) in the presence of an oxidizing agent and a diluent. Get. In the reaction (e), an azole derivative (IIc) in which X 1 is —SR 2 can be used instead of the azole derivative (IIa).
 酸化剤としては硫黄の酸化に一般的に使用される全ての物質を挙げることができ、例えば、過酸化水素;過酢酸およびメタクロロ過安息香酸等の過酸;ならびに過マンガン酸カリウム等の無機塩を好適に使用し得る。 The oxidizing agent can include all substances commonly used for the oxidation of sulfur, such as hydrogen peroxide; peracids such as peracetic acid and metachloroperbenzoic acid; and inorganic salts such as potassium permanganate. Can be suitably used.
 希釈剤は類似の反応に一般的に使用される全ての溶媒を挙げることができる。例えば、酸化剤として過酸化水素または過酸を用いる場合、希釈剤として酢酸または氷酢酸を好適に使用し得る。酸化剤として過マンガン酸カリウムを用いる場合、水またはt-ブタノール等のアルコールを好適に使用し得る。 Diluents can include all solvents commonly used in similar reactions. For example, when hydrogen peroxide or peracid is used as the oxidizing agent, acetic acid or glacial acetic acid can be suitably used as the diluent. When potassium permanganate is used as the oxidizing agent, water or alcohol such as t-butanol can be preferably used.
 反応温度は、例えば、0℃~100℃であり、好ましくは10℃~100℃である。 The reaction temperature is, for example, 0 ° C. to 100 ° C., preferably 10 ° C. to 100 ° C.
 SO化合物を合成しようとする場合、酸化剤の使用量は、Xが-SRであるアゾール誘導体(IIc)に対し、等価量が好ましい。一方、SO化合物を合成しようとする場合、酸化剤の使用量は、Xが-SRであるアゾール誘導体(IIc)に対し、過剰量が好ましい。 When an SO compound is to be synthesized, the oxidant is preferably used in an equivalent amount relative to the azole derivative (IIc) in which X 1 is —SR 2 . On the other hand, when an SO 2 compound is to be synthesized, the oxidant is preferably used in an excess amount relative to the azole derivative (IIc) in which X 1 is —SR 2 .
 以上、アゾール誘導体(IIa)あるいはアゾール誘導体(IIb)から、アゾール誘導体(Ib)以外のアゾール誘導体(I)を製造する方法について説明したが、アゾール誘導体(I)の製造方法はこれに限定されるものではない、例えば、アゾール誘導体(Ia)またはアゾール誘導体(Ib)に対して上述の反応(c)、(d)または(e)と同様の反応を行なうことにより、アゾール誘導体(Ib)以外のアゾール誘導体(I)を製造するものであってもよい。 As mentioned above, although the method to manufacture azole derivative (I) other than azole derivative (Ib) from azole derivative (IIa) or azole derivative (IIb) was demonstrated, the manufacturing method of azole derivative (I) is limited to this. For example, by reacting the azole derivative (Ia) or the azole derivative (Ib) with the reaction similar to the above reaction (c), (d) or (e), other than the azole derivative (Ib) The azole derivative (I) may be produced.
 上述のように、反応(a)または反応(b)により得られるアゾール誘導体(IIa)およびアゾール誘導体(IIb)ならびに反応(c)、反応(d)または反応(e)により得られるアゾール誘導体(IIc)は、アゾール誘導体(I)を製造するための中間体化合物として、アゾール誘導体(I)の製造に好適に用いられる。そのため、アゾール誘導体(IIa)および下記一般式(II)で示されるアゾール誘導体(II)もまた、アゾール誘導体(I)を製造するための好適な中間体化合物として、本発明の範疇に含まれる。 As described above, the azole derivative (IIa) and the azole derivative (IIb) obtained by the reaction (a) or the reaction (b) and the azole derivative (IIc) obtained by the reaction (c), the reaction (d) or the reaction (e). ) Is suitably used for the production of the azole derivative (I) as an intermediate compound for producing the azole derivative (I). Therefore, the azole derivative (IIa) and the azole derivative (II) represented by the following general formula (II) are also included in the category of the present invention as suitable intermediate compounds for producing the azole derivative (I).
Figure JPOXMLDOC01-appb-C000020
Figure JPOXMLDOC01-appb-C000020
(一般式(II)中、R、X、Y、mおよびAは、それぞれ上記一般式(I)におけるR、X、Y、mおよびAと同じである。)
 同様に、アゾール誘導体(II)をハロゲン酸と反応させてアゾール誘導体(I)を得る工程を含む、アゾール誘導体(I)の製造方法もまた、本発明の範疇に含まれる。
(In the general formula (II), R 1, X , Y 2, m and A are each the same as R 1, X, Y 2, m and A in the general formula (I).)
Similarly, a method for producing the azole derivative (I) including a step of obtaining the azole derivative (I) by reacting the azole derivative (II) with a halogen acid is also included in the scope of the present invention.
 (アゾール誘導体(III)の製造方法)
 アゾール誘導体(III)のうち、Rがアルキル基または水素原子であるアゾール誘導体(III)は、公知の方法(例えば、特許文献1に記載の方法)によって製造される化合物を使用すればよい。
(Method for producing azole derivative (III))
Among the azole derivatives (III), the azole derivative (III) in which R 1 is an alkyl group or a hydrogen atom may be a compound produced by a known method (for example, the method described in Patent Document 1).
 アゾール誘導体(III)のうち、Rがアルコキシ基であるアゾール誘導体(以下、アゾール誘導体(IIIa)と称する)については、例えば、反応スキーム2に示す各工程により、下記一般式(VII)で示されるアゾール誘導体(以下、アゾール誘導体(VII)と称する)から製造することができる。なお、アゾール誘導体(VII)は、公知の方法(例えば、特許文献1に記載の方法)によって製造される化合物を使用すればよい。 Among the azole derivatives (III), an azole derivative in which R 1 is an alkoxy group (hereinafter referred to as azole derivative (IIIa)) is represented by the following general formula (VII) by, for example, each step shown in Reaction Scheme 2. Azole derivative (hereinafter referred to as azole derivative (VII)). In addition, what is necessary is just to use the compound manufactured by a well-known method (for example, the method of patent document 1) as azole derivative (VII).
Figure JPOXMLDOC01-appb-C000021
Figure JPOXMLDOC01-appb-C000021
 以下、反応スキーム2に示す各工程について説明する。 Hereinafter, each step shown in Reaction Scheme 2 will be described.
 (閉環工程)
 閉環工程では、アゾール誘導体(VII)を閉環することにより一般式(VI)で示されるアゾール誘導体(以下、アゾール誘導体(VI)と称する)を得る。閉環によるアゾール誘導体(VI)の好適な合成方法としては、アゾール誘導体(VII)をスルホニルクロライド類および過剰量塩基の存在下、溶媒中で反応させる方法を挙げることができる。
(Ring closure process)
In the ring closing step, the azole derivative (VII) is closed to obtain an azole derivative represented by the general formula (VI) (hereinafter referred to as azole derivative (VI)). A preferred method for synthesizing the azole derivative (VI) by ring closure includes a method of reacting the azole derivative (VII) in a solvent in the presence of a sulfonyl chloride and an excess amount of a base.
 スルホニルクロライド類としては、p-トルエンスルホニルクロライド、およびメタンスルホニルクロライド等を用いることができる。これらの中でも、p-トルエンスルホニルクロライドを用いることが好ましい。 As the sulfonyl chlorides, p-toluenesulfonyl chloride, methanesulfonyl chloride and the like can be used. Of these, p-toluenesulfonyl chloride is preferably used.
 また、塩基は特に限定されるものではないが、例えば、水素化ナトリウム等の金属水素化合物、ならびにナトリウムメトキシド、ナトリウムエトキシド、ナトリウムt-ブトキシドおよびカリウムt-ブトキシド等のアルカリ金属のアルコキシド等を好適に用いることができる。これらの中でも、水素化ナトリウムをより好適に用いることができる。 The base is not particularly limited, and examples thereof include metal hydride compounds such as sodium hydride, and alkali metal alkoxides such as sodium methoxide, sodium ethoxide, sodium t-butoxide and potassium t-butoxide. It can be used suitably. Among these, sodium hydride can be used more suitably.
 スルホニルクロライド類の量は、アゾール誘導体(VII)に対して1~2倍モルであることが好ましい。塩基の量は、アゾール誘導体(VII)に対して2.5~10倍モルであることが好ましく、2.8~6倍モルであることがより好ましい。 The amount of sulfonyl chlorides is preferably 1 to 2 moles relative to the azole derivative (VII). The amount of the base is preferably 2.5 to 10-fold mol, more preferably 2.8 to 6-fold mol based on the azole derivative (VII).
 溶媒は、特に限定されるものではないが、例えば、N-メチルピロリドンおよびN,N-ジメチルホルムアミド等のアミド類、テトラヒドロフランおよびジオキサン等のエーテル類、ジメチルスルホキシドならびにこれらの混合溶媒を用いることができる。これらの中でも、テトラヒドロフランを好適に用いることができる。 The solvent is not particularly limited. For example, amides such as N-methylpyrrolidone and N, N-dimethylformamide, ethers such as tetrahydrofuran and dioxane, dimethyl sulfoxide, and a mixed solvent thereof can be used. . Among these, tetrahydrofuran can be preferably used.
 反応温度は、用いられる溶媒、アゾール誘導体(VII)、スルホニルクロライド類および塩基等の種類によって適宜設定することができるが、好適には-100℃~200℃であり、より好適には-50℃~150℃である。反応時間は、用いられる溶媒、アゾール誘導体(VII)、スルホニルクロライド類および塩基等の種類によって適宜設定することができるが、好適には0.1時間~数日であり、より好適には0.5時間~2日である。 The reaction temperature can be appropriately set depending on the type of solvent, azole derivative (VII), sulfonyl chlorides, base and the like used, but is preferably −100 ° C. to 200 ° C., more preferably −50 ° C. ~ 150 ° C. The reaction time can be appropriately set depending on the type of solvent, azole derivative (VII), sulfonyl chlorides, base and the like to be used, but is preferably 0.1 hour to several days, more preferably 0. 5 hours to 2 days.
 (アルキル化工程)
 アルキル化工程では、アゾール誘導体(VI)のヒドロキシ基をアルキル化することによりアゾール誘導体(IIIa)を得る。なお、一般式(IIIa)中、Rは、炭素数1~3のアルキル基である。アルキル化の方法としては特に限定されないが、溶媒中において、アゾール誘導体(VI)のヒドロキシ基とアルカリ金属塩基とから調製される金属アルコキシドを、脱離基を有する炭素数1~3のアルキル化合物と室温にて反応させる方法を挙げることができる。
(Alkylation process)
In the alkylation step, the azole derivative (IIIa) is obtained by alkylating the hydroxy group of the azole derivative (VI). In general formula (IIIa), R 5 is an alkyl group having 1 to 3 carbon atoms. The alkylation method is not particularly limited, but a metal alkoxide prepared from a hydroxy group of the azole derivative (VI) and an alkali metal base in a solvent is converted to an alkyl compound having 1 to 3 carbon atoms having a leaving group. The method of making it react at room temperature can be mentioned.
 溶媒としては、テトラヒドロフランなどのエーテル系の溶媒、N-メチルピロリドンおよびN,N-ジメチルホルムアミド等のアミド類の溶媒、ベンゼンおよびトルエン等の芳香族系の溶媒、ならびに塩化メチレン等のハロゲン化物の溶媒を好適に用いることができる。これらのうち、テトラヒドロフランをより好適に用いることができる。 Solvents include ether solvents such as tetrahydrofuran, amide solvents such as N-methylpyrrolidone and N, N-dimethylformamide, aromatic solvents such as benzene and toluene, and halide solvents such as methylene chloride. Can be suitably used. Of these, tetrahydrofuran can be more preferably used.
 脱離基を有する炭素数1~3のアルキル化合物としては、アルキルの炭素数が1~3であるヨウ化アルキルおよび臭化アルキル等のハロゲン化アルキル、ならびにアルキルの炭素数が1~3のトシルオキシアルキルおよびメシルオキシアルキル等のスルホン酸エステルを挙げることができる。これらのうち、ヨウ化アルキルを好適に用いることができる。さらに、ヨウ化アルキルの中では、ヨウ化メチルを用いることがより好ましい。 Examples of the alkyl compound having 1 to 3 carbon atoms having a leaving group include alkyl halides such as alkyl iodide and alkyl bromide in which alkyl has 1 to 3 carbon atoms, and tosyl in which alkyl has 1 to 3 carbon atoms. Mention may be made of sulfonate esters such as oxyalkyl and mesyloxyalkyl. Of these, alkyl iodide can be preferably used. Furthermore, among alkyl iodides, it is more preferable to use methyl iodide.
 アルカリ金属塩基としては、ナトリウム、水素化ナトリウム、水酸化ナトリウム、および水酸化カリウムを挙げることができる。これらのうち、水素化ナトリウムを用いることが好ましい。 Examples of the alkali metal base include sodium, sodium hydride, sodium hydroxide, and potassium hydroxide. Of these, sodium hydride is preferably used.
 〔3.農園芸用薬剤〕
 アゾール誘導体(I)および(Ia)は、1,2,4-トリアゾリル基もしくはイミダゾリル基を有するので、無機酸および有機酸の酸付加塩、または金属錯体を形成する。したがって、酸付加塩および金属錯体の一部として、農園芸用薬剤等の有効成分として使用することができる。
[3. (Agricultural and horticultural chemicals)
Since the azole derivatives (I) and (Ia) have a 1,2,4-triazolyl group or an imidazolyl group, they form acid addition salts of inorganic acids and organic acids, or metal complexes. Therefore, it can be used as an active ingredient such as agricultural and horticultural agents as part of acid addition salts and metal complexes.
 (1)植物病害防除効果
 アゾール誘導体(I)および(Ia)は、広汎な植物病害に対して防除効果を呈する。適用病害の例として以下が挙げられる:ダイズさび病(Phakopsora pachyrhizi、Phakopsora meibomiae)、イネいもち病(Pyricularia grisea)、イネごま葉枯病(Cochliobolus miyabeanus)、イネ白葉枯病(Xanthomonas oryzae)、イネ紋枯病(Rhizoctonia solani)、イネ小黒菌核病(Helminthosporium sigmoideun)、イネばか苗病(Gibberella fujikuroi)、イネ苗立枯病(Pythium aphanidermatum)、リンゴうどんこ病(Podosphaeraleucotricha)、リンゴ黒星病(Venturia inaequalis)、リンゴモリニア病(Moniliniamali)、リンゴ斑点落葉病(Alternaria alternata)、リンゴ腐乱病(Valsa mali)、
ナシ黒斑病(Alternaria kikuchiana)、ナシうどんこ病(Phyllactinia pyri)、ナシ赤星病(Gymnosporangium asiaticum)、ナシ黒星病(Venturia nashicola)、ブドウうどんこ病(Uncinula necator)、ブドウべと病(Plasmopara viticola)、ブドウ晩腐病(Glomerella cingulata)、オオムギうどんこ病(Erysiphe graminis f. sp hordei)、オオムギ黒さび病(Puccinia graminis)、オオムギ黄さび病(Puccinia striiformis)、オオムギ斑葉病(Pyrenophora graminea)、オオムギ雲形病(Rhynchosporium secalis)、コムギうどんこ病(Erysiphe graminis f. sp tritici)、コムギ赤さび病(Puccinia recondita)、コムギ黄さび病(Puccinia striiformis)、コムギ眼紋病(Pseudocercosporella herpotrichoides)、コムギ赤かび病(Fusarium graminearum、Microdochium nivale)、コムギふ枯病(Phaeosphaeria nodorum)、コムギ葉枯病(Septoria tritici)、ウリ類うどんこ病(Sphaerotheca fuliginea)、ウリ類の炭疸病(Colletotrichum lagenarium)、キュウリべと病(Pseudoperonospora cubensis)、キュウリ灰色疫病(Phytophthora capsici)、トマトうどんこ病(Erysiphe cichoracearum)、トマト輪紋病(Alternaria solani)、ナスうどんこ病(Erysiphe cichoracearum)、イチゴうどんこ病(Sphaerotheca humuli)、タバコうどんこ病(Erysiphe cichoracearum)、テンサイ褐斑病(Cercospora beticola)、トウモロコシ黒穂病(Ustilago maydis)、核果類果樹の灰星病(Monilinia fructicola)、種々の作物をおかす灰色かび病(Botrytis cinerea)、および菌核病(Sclerotinia sclerotiorum)等。さらに、ブドウのさび病(Phakopsora ampelopsidis)、スイカのつる割病(Fusarium oxysporumf.sp.niveum)、キュウリのつる割病(Fusarim oxysporumf.sp.cucumerinum)、ダイコンの萎黄病(Fusarium oxysporumf.sp.raphani)、タバコの赤星病(Alternaria longipes)、ジャカイモの夏疫病(Alternaria solani)、ダイズの褐紋病(Septoria glycines)、およびダイズの紫斑病(Cercospora kikuchii)等が挙げられる。
(1) Plant disease control effect The azole derivatives (I) and (Ia) exhibit a control effect on a wide range of plant diseases. Examples of applicable diseases include: soybean rust (Phakopsora pachyrhizi, Phakopsora meibomiae), rice blast (Pyricularia grisea), rice sesame leaf (Cochliobolus miyabeanus), rice leaf blight (Xanthomonas oryzae), rice crest Blight (Rhizoctonia solani), rice small black rot (Helminthosporium sigmoideun), rice seedling disease (Gibberella fujikuroi), rice seedling blight (Pythium aphanidermatum), apple powdery mildew (Podosphaeraleucotricha), apple black infestation (Ventia qualia) ), Apple morinia disease (Moniliniamali), apple spotted leaf disease (Alternaria alternata), apple rot disease (Valsa mali),
Pear black spot disease (Alternaria kikuchiana), pear powdery mildew (Phyllactinia pyri), pear red star disease (Gymnosporangium asiaticum), pear black spot disease (Venturia nashicola), grape powdery mildew (Uncinula necator), grape mildew (Plasmopara viticola) ), Grape late rot (Glomerella cingulata), Barley powdery mildew (Erysiphe graminis f. Sp hordei), Barley black rust (Puccinia graminis), Barley yellow rust (Puccinia striiformis), Barley leaf rot (Pyrenophora graminea) , Barley cloud disease (Rhynchosporium secalis), wheat powdery mildew (Erysiphe graminis f. Sp tritici), wheat red rust (Puccinia recondita), wheat yellow rust (Puccinia striiformis), wheat eye spot (Pseudocercosporella herpotrichoides) Fungus (Fusarium graminearum, Microdochium nivale), wheat blight (Phaeosphaeria nodorum), wheat leaf blight (Septoria tritici), cucurbits This disease (Sphaerotheca fuliginea), cucumber anthracnose (Colletotrichum lagenarium), cucumber downy mildew (Pseudoperonospora cubensis), cucumber gray plague (Phytophthora capsici), tomato powdery mildew (Erysiphe cichoracearum), tomato ring rot disease (Alternaria solani) ), Eggplant powdery mildew (Erysiphe cichoracearum), strawberry powdery mildew (Sphaerotheca humuli), tobacco powdery mildew (Erysiphe cichoracearum), sugar beet brown spot (Cercospora beticola), corn smut (Ustilago maydis), fruit tree Monilinia fructicola, gray mold disease (Botrytis cinerea) that causes various crops, and sclerotia disease (Sclerotinia sclerotiorum). In addition, grape rust (Phakopsora ampelopsidis), watermelon vine (Fusarium oxysporumf.sp.niveum), cucumber vine (Fusarim oxysporumf.sp.cucumerinum), radish yellow (Fusarium oxysporumf.sp.raphani) ), Tobacco red streak (Alternaria longipes), potato summer rot (Alternaria solani), soybean brown spot (Septoria glycines), soybean purpura (Cercospora kikuchii), and the like.
 また、適用植物の例としては、野生植物、植物栽培品種、異種交配もしくは原形質融合などの従来の生物育種によって得られる植物および植物栽培品種、ならびに遺伝子操作によって得られる遺伝子組み換え植物および植物栽培品種が挙げられる。遺伝子組み換え植物および植物栽培品種としては、例えば、除草剤耐性作物、殺虫性タンパク産生遺伝子を組み込んだ害虫耐性作物、病害に対する抵抗性誘導物質産生遺伝子を組み込んだ病害耐性作物、食味向上作物、収量向上作物、保存性向上作物および収量向上作物等が挙げられる。遺伝子組み換え植物栽培品種としては、具体的に、ROUNDUP READY、LIBERTY LINK、CLEARFIELD、YIELDGARD、HERCULEX、BOLLGARD等の登録商標を含むものが挙げられる。 Examples of applicable plants include wild plants, plant cultivars, plants and plant cultivars obtained by conventional biological breeding such as crossbreeding or protoplast fusion, and genetically modified plants and plant cultivars obtained by genetic manipulation. Is mentioned. Examples of genetically modified plants and plant cultivars include herbicide-tolerant crops, pest-tolerant crops incorporating insecticidal protein production genes, disease-resistant crops incorporating resistance-inducing substance production genes against diseases, food-enhancing crops, and yield improvement Examples include crops, crops with improved shelf life and crops with improved yield. Specific examples of genetically modified plant cultivars include those containing registered trademarks such as ROUNDUP READY, LIBERTY LINK, CLEARFIELD, YIELDGARD, HERCULEX, BOLLGARD and the like.
 (2)植物生長作用
 また、アゾール誘導体(I)および(Ia)は、広汎な作物および園芸植物に対して、その成長を調節して収量を増加させる効果、およびその品質を高める効果等を示す。かかる作物の例として以下が挙げられる:コムギ・大麦・燕麦などの麦類、稲、ナタネ、サトウキビ、トウモロコシ、メイズ、大豆、エンドウ、落花生、シュガービート、キャベツ、ニンニク、ダイコン、ニンジン、リンゴ、ナシ、みかん・オレンジ・レモンなどの柑橘類、モモ、桜桃、アボガド、マンゴー、パパイヤ、トウガラシ、キュウリ、メロン、イチゴ、タバコ、トマト、ナス、芝、菊、ツツジ、およびその他の観賞用植物。
(2) Plant growth action In addition, the azole derivatives (I) and (Ia) have the effect of increasing the yield by adjusting the growth and the effect of improving the quality of a wide variety of crops and horticultural plants. . Examples of such crops include: wheat, barley, buckwheat and other wheat, rice, rapeseed, sugarcane, corn, maize, soybeans, peas, peanuts, sugar beet, cabbage, garlic, radish, carrots, apples, pears Citrus fruits such as oranges, oranges, lemons, peaches, cherry peaches, avocados, mangoes, papayas, peppers, cucumbers, melons, strawberries, tobacco, tomatoes, eggplants, grass, chrysanthemums, azaleas, and other ornamental plants.
 (3)工業材料保護効果
 さらに、アゾール誘導体(I)および(Ia)は、工業材料を侵す広汎な有害微生物から材料を保護する優れた効果を示す。かかる微生物の例として以下が挙げられる:紙・パルプ劣化微生物(スライム形成菌を含む)であるアスペルギルス(Aspergillus sp.)、トリコデルマ(Trichoderma sp.)、ペニシリウム(Penicillium sp.)、ジェオトリカム(Geotrichum sp.)、ケトミウム(Chaetomium sp.)、カドホーラ(Cadophora sp.)、セラトストメラ(Ceratostomella sp.)、クラドスボリウム(Cladosporium sp.)、コーティシウム(Corticium sp.)、レンティヌス(Lentinus sp.)、レンズィテス(Lenzites sp.)、フォーマ(Phoma sp.)、ポリスティクス(Polysticus sp.)、プルラリア(Pullularia sp.)、ステレウム(Stereum sp.)、トリコスポリウム(Trichosporium sp.)、アエロバクタ-(Aerobacter sp.)、バシルス(Bacillus sp.)、デスルホビブリオ(Desulfovibrio sp.)、シュードモナス(Pseudomonas sp.)、フラボバクテリウム(Flavobacterium sp.)、およびミクロコツカス(Micrococcus sp.)など、繊維劣化微生物であるアスペルギルス(Aspergillus sp.)、ペニシリウム(Penicillium sp.)、ケトミウム(Chaetomium sp.)、ミロテシウム(Myrothecium sp.)、クルブラリア(Curvularia sp.)、グリオマスティックス、(Gliomastix sp.)、メンノニエラ(Memnoniella sp.)、サルコポディウム(Sarcopodium sp.)、スタキボトリス(Stschybotrys sp.)、ステムフィリウム(Stemphylium sp.)、ジゴリンクス(Zygorhynchus sp.)、バシルス(bacillus sp.)、およびスタフィロコッカス(Staphylococcus sp.)など、木材変質菌であるオオウズラタゲ(Tyromyces palustris)、カワラタケ(Coriolus versicolor)、アスペルギルス(Aspergillus sp.)、ペニシリウム(Penicillium sp.)、リゾプス(Rhizopus sp.)、オーレオバシディウム(Aureobasidium sp.)、グリオクラデイウム(Gliocladum sp.)、クラドスポリウム(Cladosporium sp.)、ケトミウム(Chaetomium sp.)、およびトリコデルマ(Trichoderma sp.)など、皮革劣化微生物であるアスペルギルス(Aspergillus sp.)、ペニシリウム(Penicillium sp.)、ケトミウム(Chaetomium sp.)、クラドスポリウム(Cladosporium sp.)、ムコール(Mucor sp.)、パエシロミセス(Paecilomyces sp.)、ピロブス(Pilobus sp.)、プルラリア(Pullularia sp.)、トリコスポロン(Trichosporon sp.)、およびトリコテシウム(Tricothecium sp.)など、ゴム・プラスチック劣化微生物であるアスペルギルス(Aspergillus sp.)、ペニシリウム(Penicillium sp.)、リゾプス(Rhizopus sp.)、トリコデルマ(Trichoderma sp.)、ケトミウム(Chaetomium sp.)、ミロテシウム(Myrothecium sp.)、ストレプトマイセス(Streptomyces sp.)、シュードモナス(Pseudomonas sp.)、バシルス(Bacillus sp.)、ミクロコツカス(Micrococcus sp.)、セラチア(Serratia sp.)、マルガリノマイセス(Margarinomyces sp.)、およびモナスクス(Monascus sp.)など、ならびに塗料劣化微生物であるアスペルギルス(Aspergillus sp.)、ペニシリウム(Penicillium sp.)、クラドスポリウム(Cladosporium sp.)、オーレオバシディウム(Aureobasidium sp.)、グリオクラディウム(Gliocladium sp.)、ボトリオディプロディア(Botryodiplodia sp.)、マクロスポリウム(Macrosporium sp.)、モニリア(Monilia sp.)、フォーマ(Phoma sp.)、プルラリア(Pullularia sp.)、スポロトリカム(Sporotrichum sp.)、トリコデルマ(Trichoderma sp.)、バシルス(bacillus sp.)、プロテウス(Proteus sp.)、シュードモナス(Pseudomonas sp.)、およびセラチア(Serratia sp.)。
(3) Industrial Material Protection Effect Furthermore, the azole derivatives (I) and (Ia) exhibit an excellent effect of protecting the material from a wide range of harmful microorganisms that invade the industrial material. Examples of such microorganisms include: Aspergillus sp., Trichoderma sp., Penicillium sp., Geotrichum sp., Which are paper and pulp-degrading microorganisms (including slime-forming bacteria). ), Ketomium (Caetomium sp.), Cadophora sp., Ceratostomella sp., Cladosporium sp., Corticium sp., Lentinus sp., Lenzites sp.), Forma sp., Polysticus sp., Pullularia sp., Stereum sp., Trichosporium sp., Aerobacter sp., Bacillus sp., Desulfovibrio sp., Pseudomonas sp., Flavobacterium ( Flavobacterium sp.) And fiber-degrading microorganisms such as Micrococcus sp., Aspergillus sp., Penicillium sp., Chaetomium sp., Myrothecium sp., Curvularia sp.), Gliomastix sp., Mennoniella sp., Sarcopodium sp., Stschybotrys sp., Stemphylium sp., Zygorhynchus sp .), Bacillus sp., And Staphylococcus sp., Wood-modifying fungi such as Tyromyces palustris, Coriolus versicolor, Aspergillus sp., Penicillium sp. ), Rhizopus sp., Aureobasidium sp., Aspergillus sp. And Penicillium sp., Skin-degrading microorganisms, such as Gliocladum sp., Cladosporium sp., Chaetomium sp., And Trichoderma sp. , Ketomium (Chaetomium sp.), Cladosporium (Cl.sporium sp.), Mucor (Mucor sp.), Paecilomyces sp., Pilobus (Pilobus sp.), Pullularia (Pullularia sp.), Trichosporon sp. ), And Aspergillus sp., Penicillium sp., Rhizopus sp., Trichoderma sp., Trichoderma sp., And Chaetomium sp, such as Tricothecium sp. .), Myrothecium sp., Streptomyces sp. Demonas (Pseudomonas sp.), Bacillus (Bacillus sp.), Micrococcus (Micrococcus sp.), Serratia (Serratia sp.), Margarinomyces sp., And Monascus sp. Microorganisms Aspergillus sp., Penicillium sp., Cladosporium sp., Aureobasidium sp., Gliocladium sp., Botryo diprodia (Botryodiplodia sp.), Macrosporium sp., Monilia sp., Forma (Phoma sp.), Pullularia sp., Sporotrichum sp., Trichoderma sp., Bacillus sp., Proteus sp., Pseudomonas sp., And Serratia sp.
 (4)製剤
 アゾール誘導体(I)または(Ia)を農園芸用薬剤の有効成分として適用するには、他の何らかの成分も加えずそのままでもよいが、通常は固体担体または液体担体、界面活性剤およびその他の製剤補助剤等と混合して粉剤、水和剤、粒剤および乳剤などの種々の形態に製剤して使用する。
(4) Formulation In order to apply the azole derivative (I) or (Ia) as an active ingredient of an agricultural or horticultural agent, it may be left as it is without adding any other components, but usually a solid carrier or a liquid carrier, a surfactant. And mixed with other formulation adjuvants, etc. to be used in various forms such as powders, wettable powders, granules and emulsions.
 これらの製剤には有効成分としてアゾール誘導体(I)または(Ia)を、0.1~95重量%、好ましくは0.5~90重量%、より好ましくは2~80重量%含まれるように製剤する。 These preparations contain 0.1 to 95% by weight, preferably 0.5 to 90% by weight, more preferably 2 to 80% by weight, of the azole derivative (I) or (Ia) as an active ingredient. To do.
 製剤補助剤として使用する固体坦体、液体担体(液体希釈剤)および界面活性剤を例示すれば、まず、固体坦体として、タルク、カオリン、ベントナイト、珪藻土、ホワイトカーボンおよびクレー等が挙げられる。液体希釈剤としては、水、キシレン、トルエン、クロロベンゼン、シクロヘキサン、シクロヘキサノン、ジメチルスルホキシド、ジメチルホルムアミドおよびアルコール等が挙げられる。界面活性剤は、その効果により使い分けるのがよく、乳化剤としては、ポリオキシエチレンアルキルアリールエーテルおよびポリオキシエチレンソルビタンモノラウレート等を挙げることができ、分散剤としては、リグニンスルホン酸塩およびジブチルナフタリンスルホン酸塩等を挙げることができ、湿潤剤としては、アルキルスルホン酸塩およびアルキルフェニルスルホン酸塩等を挙げることができる。 Examples of solid carriers, liquid carriers (liquid diluents) and surfactants used as formulation adjuvants include talc, kaolin, bentonite, diatomaceous earth, white carbon, and clay as solid carriers. Examples of the liquid diluent include water, xylene, toluene, chlorobenzene, cyclohexane, cyclohexanone, dimethyl sulfoxide, dimethylformamide and alcohol. Surfactants should be properly used depending on their effects. Examples of emulsifiers include polyoxyethylene alkylaryl ether and polyoxyethylene sorbitan monolaurate. Dispersants include lignin sulfonate and dibutyl naphthalene. Examples of the wetting agent include alkyl sulfonates and alkyl phenyl sulfonates.
 製剤には、そのまま使用するものと水等の希釈剤で所定濃度に希釈して使用するものとがある。希釈して使用するときのアゾール誘導体(I)の濃度は0.001~1.0%の範囲が望ましい。 Some preparations are used as they are, while others are diluted to a predetermined concentration with a diluent such as water. The concentration of the azole derivative (I) when diluted is preferably in the range of 0.001 to 1.0%.
 また、アゾール誘導体(I)および(Ia)の使用量は、畑、田、果樹園および温室等の農園芸地1haあたり、20~5000g、より好ましくは50~2000gである。これらの使用濃度および使用量は剤形、使用時期、使用方法、使用場所および対象作物等によっても異なるため、上記の範囲にこだわることなく増減することが可能である。 In addition, the amount of the azole derivatives (I) and (Ia) used is 20 to 5000 g, more preferably 50 to 2000 g per 1 ha of agricultural and horticultural lands such as fields, fields, orchards and greenhouses. Since these use concentrations and amounts vary depending on the dosage form, use time, use method, use place, target crop, etc., they can be increased or decreased without sticking to the above range.
 さらに、アゾール誘導体(I)および(Ia)は他の有効成分、例えば以下に例示するような殺菌剤、殺虫剤、殺ダニ剤、および除草剤等と組み合わせ、農園芸用薬剤としての性能を高めて使用することもできる。 Further, the azole derivatives (I) and (Ia) are combined with other active ingredients such as fungicides, insecticides, acaricides and herbicides as exemplified below to enhance performance as agricultural and horticultural agents. Can also be used.
 <抗菌性物質>
 アシベンゾラーSメチル、2-フェニルフェノール(OPP)、アザコナゾール、アゾキシストロビン、アミスルブロム、ビキサフェン、ベナラキシル、ベノミル、ベンチアバリカルブ-イソプロピル、ビカルボネイト、ビフェニル、ビテルタノール、ブラスチシジン-S、ボラックス、ボルドー液、ボスカリド、ブロムコナゾール、ブロノポール、ブピリメート、セックブチラミン、カルシウムポリスルフィド、カプタフォル、キャプタン、カルベンダジム、カルボキシン、カルプロパミド、キノメチオネート、クロロネブ、クロロピクリン、クロロタロニル、クロゾリネート、シアゾファミド、シフルフェナミド、シモキサニル、シプロコナゾール、シプロジニル、ダゾメット、デバカルブ、ジクロフルアニド、ジクロシメット、ジクロメジン、ジクロラン、ジエトフェンカルブ、ジフェノコナゾール、ジフルメトリン、ジメトモルフ、ジメトキシストロビン、ジニコナゾール、ジノカップ、ジフェニルアミン、ジチアノン、ドデモルフ、ドジン、エディフェンフォス、エポキシコナゾール、エタポキサム、エトキシキン、エトリジアゾール、エネストロブリン、ファモキサドン、フェナミドン、フェナリモル、フェンブコナゾール、フェンフラム、フェンヘキサミド、フェノキサニル、フェンピクロニル、フェンプロピジン、フェンプロピモルフ、フェンチン、フェルバム、フェリムゾン、フルアジナム、フルジオキソニル、フルモルフ、フルオロミド、フルオキサストロビン、フルキンコナゾール、フルシラゾール、フルスルファミド、フルトラニル、フルトリアフォル、フォルペット、フォセチル-アルミニウム、フベリダゾール、フララキシル、フラメトピル、フルオピコリド、フルオピラム、グアザチン、ヘキサクロロベンゼン、ヘキサコナゾール、ヒメキサゾール、イマザリル、イミベンコナゾール、イミノクタジン、イプコナゾール、イプロベンフォス、イプロジオン、イプロバリカルブ、イソプロチオラン、イソピラザム、イソチアニル、カスガマイシン、銅調製物例えば水酸化銅、ナフテン酸銅、オキシ塩化銅、硫酸銅、酸化銅、オキシン-銅、クレゾキシムメチル、マンコカッパー、マンコゼブ、マネブ、マンジプロパミド、メパニピリム、メプロニル、メタラキシル、メトコナゾール、メチラム、メトミノスウトロビン、ミルジオマイシン、ミクロブタニル、ニトロタル-イソプロピル、ヌアリモル、オフレース、オキサジキシル、オキソリニック酸、オキスポコナゾール、オキシカルボキシン、オキシテトラサイクリン、ペフラゾエート、オリサストロビン、ペンコナゾール、ペンシクロン、ペンチオピラド、ピリベンカルブ、フサライド、ピコキシストロビン、ピペラリン、ポリオキシン、プロベナゾール、プロクロラズ、プロシミドン、プロパモカルブ、プロピコナゾール、プロピネブ、プロキナジド、プロチオコナゾール、ピラクロストロビン、ピラゾフォス、ピリフェノックス、ピリメタニル、ピロキロン、キノキシフェン、キントゼン、シルチオファム、シメコナゾール、スピロキサミン、硫黄および硫黄調製物、テブコナゾール、テクロフタラム、テクナゼン、テトラコナゾール、チアベンダゾール、チフルザミド、チオファネート-メチル、チラム、チアジニル、トルクロフォス-メチル、トリルフルアニド、トリアジメフォン、トリアジメノール、トリアゾキシド、トリシクラゾール、トリデモルフ、トリフロキシストロビン、トリフルミゾール、トリホリン、トリチコナゾール、バリダマイシン、ビンクロゾリン、ジネブ、ジラム、ゾキサミド、アミスルブロム、セダキサン、フルチアニル、バリフェナール、アメトクトラジン、ジモキシストロビン、メトラフェノン、ヒドロキシイソキサゾール、フルキサピロキサドならびにメタスルホカルブ等。
<Antimicrobial substances>
Acibenzolar S-methyl, 2-phenylphenol (OPP), azaconazole, azoxystrobin, amisulbrom, bixaphene, benalaxyl, benomyl, bench avaricarb-isopropyl, bicarbonate, biphenyl, viteltanol, blasticidin-S, borax, bordeaux, boscalid, Bromuconazole, bronopol, bupirimate, secbutyramine, calcium polysulfide, captafor, captan, carbendazim, carboxin, carpropamide, quinomethionate, chloronebu, chloropicrin, chlorothalonil, clozolinate, cyazofamide, cyflufenamide, simoxanil, cyproconil, cyprodiazole Dazomet, debacarb, diclofuranide, diclocimet, dicro Gin, Dichlorane, Dietofencarb, Difenoconazole, Diflumethrin, Dimethomorph, Dimethoxystrobin, Diniconazole, Dinocup, Diphenylamine, Dithianon, Dodemorph, Dodine, Edifenfoss, Epoxyconazole, Etapoxam, Ethoxyquin, Etridiodone, Enestropheline, Namidon Fenarimol, fenbuconazole, fenflam, fenhexamide, phenoxanyl, fenpicuronyl, fenpropidin, fenpropimorph, fentin, felvam, ferrimzone, fluazinam, fludioxonil, flumorph, fluoromide, floxastrobin, fluquinconazole, flusilazole, fursulfamide , Flutolanil, flutriafol, Olpetet, Focetyl-aluminum, Fuberidazole, Furaxil, Furametopir, Fluopicolide, Fluopyram, Guazatine, Hexachlorobenzene, Hexaconazole, Himexazole, Imazalil, Imibenconazole, Iminotazine, Ipconazole, Iprobenfos, Iprodithiol , Kasugamycin, copper preparations such as copper hydroxide, copper naphthenate, copper oxychloride, copper sulfate, copper oxide, oxine-copper, crezooxime methyl, mancocapper, mancozeb, maneb, mandipropamide, mepanipyrim, mepronil, metalaxyl, metconazole , Methylam, metminosoutrobin, myrdiomycin, microbutanyl, nitrotal-isopropyl, nuari Mole, off-race, oxadixyl, oxolinic acid, oxpoconazole, oxycarboxyl, oxytetracycline, pefrazoate, orisatrobin, penconazole, pencyclon, penthiopyrad, pyribencarb, fusalide, picoxystrobin, piperalin, polyoxin, probenazole, prochloraz, procymidone , Propamocarb, propiconazole, propinebole, proquinazide, prothioconazole, pyraclostrobin, pyrazophos, pyrifenox, pyrimethanil, pyroxylone, quinoxyphene, quintozen, silthiofam, cimeconazole, spiroxamine, sulfur and sulfur preparation, tebuconazole, teclophthalam, , Tetraconazole, thiabendazole, tifluzamide, thi Phanate-Methyl, Tyram, Thiazinyl, Torcrophos-Methyl, Tolylfluanid, Triadimefone, Triadimenol, Triazoxide, Tricyclazole, Tridemorph, Trifloxystrobin, Triflumizole, Triforin, Triticonazole, Validamycin, Vinclozoline, Zineb, ziram, zoxamide, amisulbrom, sedaxane, flutianil, varifenal, amethoctrazine, dimoxystrobin, metolaphenone, hydroxyisoxazole, floxapyroxad and metasulfocarb.
 <殺虫剤/殺ダニ剤/殺線虫剤>
 アバメクチン、アセフェート、アクリナトリン、アラニカルブ、アルジカルブ、アレトリン、アミトラズ、アベルメクチン、アザジラクチン、アザメチフォス、アジンフォス-エチル、アジンフォス-メチル、アゾサイクロチン、バシルス・フィルムス、バシルス・ズブチルス、バシルス・ツリンジエンシス、ベンジオカルブ、ベンフラカルブ、ベンスルタップ、ベンゾキシメイト、ビフェナゼイト、ビフェントリン、ビオアレトリン、ビオレスメトリン、ビストリフルロン、ブプロフェジン、ブトカルボキシン、ブトキシカルボキシン、カズサフォス、カルバリル、カルボフラン、カルボスルファン、カータップ、CGA50439、クロルデイン、クロレトキシフォス、クロルフェナピル、クロルフェンビンフォス、クロルフルアズロン、クロルメフォス、クロルピリフォス、クロルピリフォスメチル、クロマフェノザイド、クロフェンテジン、クロチアニジン、クロラントラリニプロール、コウンパフォス、クリオライト、シアノフォス、シクロプロトリン、シフルトリン、シハロトリン、シヘキサチン、シペルメトリン、シフェノトリン、シロマジン、シアザピル、シエノピラフェン、DCIP、DDT、デルタメトリン、デメトン-S-メチル、ジアフェンチウロン、ジアジノン、ジクロロフェン、ジクロロプロペン、ジクロルボス、ジコフォル、ジクロトフォス、ジシクラニル、ジフルベンズロン、ジメトエート、ジメチルビンフォス、ジノブトン、ジノテフラン、エマメクチン、エンドスルファン、EPN、エスフェンバレレート、エチオフェンカルブ、エチオン、エチプロール、エトフェンプロックス、エトプロフォス、エトキサゾール、ファムフル、フェナミフォス、フェナザキン、フェンブタチンオキシド、フェニトロチオン、フェノブカルブ、フェノチオカルブ、フェノキシカルブ、フェンプロパトリン、フェンピロキシメート、フェンチオン、フェンバレレート、フイプロニル、フロニカミド、フルアクロピリム、フルシクロクスロン、フルシトリネート、フルフェノクスロン、フルメトリン、フルバリネート、フルベンジアミド、フォルメタネート、フォスチアゼート、ハルフェンプロクス、フラチオカルブ、ハロヘノジド、ガンマ-HCH、ヘプテノフォス、ヘキサフルムロン、ヘキシチアゾックス、ヒドラメチルノン、イミダクロプリド、イミプロトリン、インドキサカルブ、イソプロカルブ、イソキサチオン、ルフェヌロン、マラチオン、メカルバム、メタム、メタミドフォス、メチダチオン、メチオカルブ、メトミル、メトプレン、メトスリン、メトキシフェノジド、メトルカルブ、ミルベメクチン、モノクロトフォス、ナレド、ニコチン、ニテンピラム、ノバルロン、ノビフルムロン、オメトエート、オキサミル、オキシデメトンメチル、パラチオン、パーメトリン、フェントエート、フォレート、フォサロン、フォスメット、フォスファミドン、フォキシム、ピリミカルブ、ピリミフォスメチル、プロフェノフォス、プロポクスル、プロチオフォス、ピメトロジン、ピラクロフォス、ピレスリン、ピリダベン、ピリダリル、ピリミジフェン、ピリプロキシフェン、ピリフルキナゾン、ピリプロール、キナルフォス、シラフルオフェン、スピノサド、スピロジクロフェン、スピロメシフェン、スピロテトラマット、スルフラミド、スルフォテップ、SZI-121、テブフェノジド、テブフェンピラド、テブピリムフォス、テフルベンズロン、テフルトリン、テメフォス、テルブフォス、テトラクロルビンフォス、チアクロプリド、チアメトキサム、チオジカルブ、チオファノックス、チオメトン、トルフェンピラド、トラロメトリン、トラロピリル、トリアザメート、トリアゾフォス、トリクロルフオン、トリフルムロン、バミドチオン、バリフェナール、XMC、キシリルカルブ、イミシアホスおよびレピメクチン等。
<Insecticide / acaricide / nematicide>
Abamectin, Acephate, Acrinathrin, Alanicarb, Aldicarb, Alletrin, Amitraz, Avermectin, Azadirachtin, Azamethifos, Azinphos-ethyl, Azinphos-methyl, Azocycline, Bacillus filmus, Bacillus subtilis, Bacillus thuringibulbbenthulbenbencarb , Benzoxymate, Bifenazite, Bifenthrin, Bioarethrin, Bioresmethrin, Bistriflurone, Buprofezin, Butocaboxin, Butoxycarboxyne, Kazusafos, Carbaryl, Carbofuran, Carbosulfan, Cartap, CGA50439, Chlordein, Chloretifol, Chlorfenapir Fenbinfoss, Chlorfluazuron Chlormefos, Chlorpyrifos, Chlorpyrifosmethyl, Chromaphenozide, Clofentedine, Clothianidin, Chloranthraliniprol, Counpafos, Cryolite, Cyanophos, Cycloproton, Cyfluthrin, Cyhalothrin, Cihexatin, Cipermethrin, Cifenotrin, Cyromazine, Ciazapyr, Sienopyrafen, DCIP, DDT, Deltamethrin, Demeton-S-methyl, Diafenthiuron, Diazinone, Dichlorophene, Dichloropropene, Dichlorvos, Dicofor, Dicrotophos, Dicyclanil, Diflubenzuron, Dimethoate, Dimethylvinphos, Franbutone, Dinobutone , Emamectin, endosulfan, EPN, esfenvalerate, etiophencarb, ethion, Tiprol, etofenprox, etoprofos, etoxazole, famflu, fenamifos, phenazaquin, fenbutatin oxide, fenitrothion, fenocarb, phenothiocarb, phenoxycarb, fenpropatrine, fenpyroximate, fenthionate, fenvalerate, fipronil, flunipyamide Ron, flucitrinate, fluphenoxuron, flumethrin, fulvalinate, flubendiamide, formethanate, fostiazate, halfenprox, furthiocarb, halohenozide, gamma-HCH, heptenofos, hexaflumuron, hexithiazox, hydramethylnon , Imidacloprid, imiprothrin, indoxacarb, isoprocar Bu, isoxathion, lufenuron, malathion, mecarbam, metham, methamidophos, methidathione, metiocarb, methomyl, methoprene, methosrine, methoxyphenozide, metorcarb, milbemectin, monocrotofos, nared, nicotine, nitenpyram, novalflumetron, oxyflumetron Tonmethyl, parathion, permethrin, phentoate, folate, fosaron, phosmet, phosphamidone, foxim, pirimicarb, pirimiphos methyl, profenofos, propoxur, prothiophos, pymetrozine, pyracrophos, pyrethrin, pyridaben, pyridalyl, pyrimidifene, pyriproxy Fen, Pyrifluquinazone, Pyriprole, Quinalfos, Shirafu Ofen, Spinosad, Spirodiclofen, Spiromethifene, Spirotetramat, Sulframide, Sulfotep, SZI-121, Tebufenozide, Tebufenpyrad, Tebupyrimfos, Teflubenzuron, Tefluthrin, Temefos, Terbufos, Tetrachlorbinfos, Thiacloprio, Thiamethioxam Fanox, thiometone, tolfenpyrad, tralomethrin, tralopyril, triazamate, triazophos, trichlorphone, triflumuron, bamidthione, varifenal, XMC, xylylcarb, imisiaphos and lepimectin.
 <植物成長調節剤>
 アンシミドール、6-ベンジルアミノプリン、パクロブトラゾール、ジクロブトラゾール、ウニコナゾール、メチルシクロプロペン、メピコートクロリド、エセフォン、クロルメコートクロライド、イナベンフィド、プロヘキサジオンおよびその塩、ならびにトリネキサパックエチル等。また、植物ホルモンとしてのジャスモン酸、ブラシノステロイドおよびジベレリン等。
<Plant growth regulator>
Ansimidol, 6-benzylaminopurine, paclobutrazole, diclobutrazole, uniconazole, methylcyclopropene, mepiquat chloride, ethephone, chlormequat chloride, inabenfide, prohexadione and salts thereof, and trinexa Pack ethyl etc. Also, jasmonic acid, brassinosteroid and gibberellin as plant hormones.
 アゾール誘導体(I)または(Ia)を工業用材料保護剤の有効成分として適用するには、他の成分を添加せずに単独で用いてもよいが、一般に、適当な液体担体に溶解するか、あるいは分散させ、または固体担体と混合し、必要に応じて、さらに乳化剤、分散剤、展着剤、浸透剤、湿潤剤および安定剤等を添加し、水和剤、粉剤、粒剤、錠剤、ペースト剤、懸濁剤および噴霧材等の剤型として使用することができる。また、他の殺菌剤、殺虫剤および劣化防止剤等を配合してもよい。 In order to apply the azole derivative (I) or (Ia) as an active ingredient of an industrial material protective agent, it may be used alone without adding other ingredients, but generally it can be dissolved in a suitable liquid carrier. Alternatively, it is dispersed or mixed with a solid carrier, and if necessary, an emulsifier, a dispersing agent, a spreading agent, a penetrating agent, a wetting agent, a stabilizer and the like are added, and a wettable powder, powder, granule, tablet It can be used as dosage forms such as pastes, suspensions and sprays. Moreover, you may mix | blend another fungicide, an insecticide, a degradation inhibitor, etc.
 液体担体としては、有効成分と反応しない限り如何なる液体を用いてもよく、例えば、水、アルコール類(例えば、メチルアルコール、エチルアルコール、エチレングリコール、およびセロソルブ等)、ケトン類(例えば、アセトン、およびメチルエチルケトン等)、エーテル類(例えばジメチルエーテル、ジエチルエーテル、ジオキサン、およびテトラヒドロフラン等)、芳香族炭化水素類(例えば、ベンゼン、トルエン、キシレン、およびメチルナフタレン等)、脂肪族炭化水素類(例えば、ガソリン、ケロシン、灯油、機械油、および燃料油等)、酸アミド類(例えば、ジメチルホルムアミド、およびN-メチルピロリドン等)、ハロゲン化炭化水素類(例えば、クロロホルム、および四塩化炭素等)、エステル類(例えば、酢酸エチルエステル、および脂肪酸のグリセリンエステル等)、ニトリル類(例えば、アセトニトリル等)ならびにジメチルスルホキシド等を使用できる。 As the liquid carrier, any liquid may be used as long as it does not react with the active ingredient. For example, water, alcohols (for example, methyl alcohol, ethyl alcohol, ethylene glycol, and cellosolve), ketones (for example, acetone, and Methyl ethyl ketone, etc.), ethers (eg, dimethyl ether, diethyl ether, dioxane, and tetrahydrofuran), aromatic hydrocarbons (eg, benzene, toluene, xylene, and methylnaphthalene), aliphatic hydrocarbons (eg, gasoline, Kerosene, kerosene, machine oil, fuel oil, etc.), acid amides (eg, dimethylformamide, N-methylpyrrolidone, etc.), halogenated hydrocarbons (eg, chloroform, carbon tetrachloride, etc.), esters ( For example, acetate Glycol ester, and glycerine esters of fatty acids, etc.), nitriles (for example, using acetonitrile, etc.), as well as dimethyl sulfoxide and the like.
 また、固体担体としては、カオリンクレー、ベントナイト、酸性白土、パイロフィライト、タルク、珪藻土、方解石、尿素および硫酸アンモニウム等の微粉末あるいは粒状物を使用できる。 As the solid support, fine powders or granular materials such as kaolin clay, bentonite, acid clay, pyrophyllite, talc, diatomite, calcite, urea and ammonium sulfate can be used.
 乳化剤および分散剤としては、石鹸類、アルキルスルホン酸、アルキルアリールスルホン酸、ジアルキルスルホコハク酸、第4級アンモニウム塩、オキシアルキルアミン、脂肪酸エステル、ポリアルキレンオキサイド系およびアンヒドロソルビトール系等の界面活性剤を使用できる。 As emulsifiers and dispersants, surfactants such as soaps, alkylsulfonic acids, alkylarylsulfonic acids, dialkylsulfosuccinic acids, quaternary ammonium salts, oxyalkylamines, fatty acid esters, polyalkylene oxides and anhydrosorbitols Can be used.
 アゾール誘導体(I)または(Ia)を有効成分として製剤中に含有させる場合、その含有割合は、剤型および使用目的によっても異なるが、一般には、0.1~99.9重量%の濃度となるように加えるのが適当である。なお、実際の使用時においては、その処理濃度は、通常0.005~5重量%、好ましくは0.01~1重量%となるように適宜、溶剤、希釈剤および増量剤等を加えて調整するのが好ましい。 When the azole derivative (I) or (Ia) is contained in the preparation as an active ingredient, the content ratio varies depending on the dosage form and the intended purpose, but in general, the concentration is 0.1 to 99.9% by weight. It is appropriate to add as follows. In actual use, the treatment concentration is usually adjusted to 0.005 to 5% by weight, preferably 0.01 to 1% by weight, by appropriately adding a solvent, a diluent, an extender and the like. It is preferable to do this.
 以上説明したように、アゾール誘導体(I)および(Ia)は、植物病害を引き起こす多くの菌に対して優れた殺菌作用を示す。また、アゾール誘導体(I)および(Ia)は植物に対する薬害が小さい。すなわち、アゾール誘導体(I)または(Ia)を有効成分として含むことにより、人畜に対する毒性が低く取扱い安全性に優れ、かつ広範な植物病害に対して高い防除効果を示すとともに、薬害の小さな農園芸用病害防除剤を実現することができる。
(付記事項)
 以上のように、本発明に係るアゾール誘導体は、下記一般式(I)または(Ia)で示されることを特徴とするアゾール誘導体である。
As described above, the azole derivatives (I) and (Ia) exhibit an excellent bactericidal action against many fungi that cause plant diseases. In addition, the azole derivatives (I) and (Ia) have little phytotoxicity to plants. That is, by including the azole derivative (I) or (Ia) as an active ingredient, it is low in toxicity to human livestock, has excellent handling safety, exhibits a high control effect on a wide range of plant diseases, and has little phytotoxicity. A disease control agent can be realized.
(Additional notes)
As described above, the azole derivative according to the present invention is an azole derivative characterized by being represented by the following general formula (I) or (Ia).
Figure JPOXMLDOC01-appb-C000022
Figure JPOXMLDOC01-appb-C000022
(一般式(I)および(Ia)中、Yは、ハロゲン原子を表し、
は、炭素数1~3のアルキル基、炭素数1~3のアルコキシ基または水素原子を表し、
は、ハロゲン原子を表し、mは、0、1または2を表し、mが2である場合には、複数あるYは互いに異なっていてもよく、
Aは、窒素原子またはメチン基を表す。
一般式(I)中、Xは、-SH、-SR、-SO-R、-SO-Rまたは-SOHを表す。Rは、炭素原子数1~6のアルキル基、炭素原子数2~6のアルケニル基、炭素原子数1~6のハロアルキル基、炭素原子数2~6のハロアルケニル基、アリール基またはアリールアルキル基(アルキル部分の炭素原子数が1~4)であり、Rにおける上記アリール基およびアリールアルキル基は、芳香環における少なくとも1つの水素原子がハロゲン原子、炭素数1~4のアルキル基(シクロアルキル基を含む)、または炭素数1~4のハロアルキル基で置換されていてもよい。)
 本発明に係るアゾール誘導体において、Yは塩素原子であることが好ましい。
(In the general formulas (I) and (Ia), Y 1 represents a halogen atom,
R 1 represents an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, or a hydrogen atom,
Y 2 represents a halogen atom, m represents 0, 1 or 2, and when m is 2, a plurality of Y 2 may be different from each other;
A represents a nitrogen atom or a methine group.
In the general formula (I), X represents —SH, —SR 2 , —SO—R 2 , —SO 2 —R 2 or —SO 3 H. R 2 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a haloalkyl group having 1 to 6 carbon atoms, a haloalkenyl group having 2 to 6 carbon atoms, an aryl group, or an arylalkyl A group (the alkyl part has 1 to 4 carbon atoms), and in the aryl group and arylalkyl group in R 2 , at least one hydrogen atom in the aromatic ring is a halogen atom, and an alkyl group having 1 to 4 carbon atoms (cyclohexane). An alkyl group), or a haloalkyl group having 1 to 4 carbon atoms. )
In the azole derivative according to the present invention, Y 1 is preferably a chlorine atom.
 また、本発明に係るアゾール誘導体は、下記一般式(Ic)または(Id)で示されるアゾール誘導体でもあり得る。 The azole derivative according to the present invention may also be an azole derivative represented by the following general formula (Ic) or (Id).
Figure JPOXMLDOC01-appb-C000023
Figure JPOXMLDOC01-appb-C000023
(一般式(Ic)および(Id)中、R、Y、YおよびAは、それぞれ上記一般式(I)および(Ia)におけるR、Y、YおよびAと同じである。一般式(Ic)中、Xは、上記一般式(I)におけるXと同じである。)
 また、本発明に係るアゾール誘導体において、Aは窒素原子であることが好ましい。
(In the general formula (Ic) and (Id), R 1, Y 1, Y 2 and A are the same as R 1, Y 1, Y 2 and A in each of the above general formula (I) and (Ia) In general formula (Ic), X is the same as X in general formula (I) above.)
In the azole derivative according to the present invention, A is preferably a nitrogen atom.
 また、本発明に係るアゾール誘導体は、下記一般式(Ie)で示されるアゾール誘導体であることが好ましい。 Further, the azole derivative according to the present invention is preferably an azole derivative represented by the following general formula (Ie).
Figure JPOXMLDOC01-appb-C000024
Figure JPOXMLDOC01-appb-C000024
(一般式(Ie)中、Yは、水素原子、フッ素原子または塩素原子を表す。)
 本発明に係る中間体化合物は、上述のアゾール誘導体を製造するために用いられる中間体化合物であって、下記一般式(II)または(IIa)で示される化合物である。
(In the general formula (Ie), Y 3 represents a hydrogen atom, a fluorine atom or a chlorine atom.)
The intermediate compound according to the present invention is an intermediate compound used for producing the above-mentioned azole derivative, and is a compound represented by the following general formula (II) or (IIa).
Figure JPOXMLDOC01-appb-C000025
Figure JPOXMLDOC01-appb-C000025
(一般式(II)および(IIa)中、R、Y、mおよびAは、それぞれ上記一般式(I)および(Ia)におけるR、Y、mおよびAと同じである。一般式(II)中、Xは、上記一般式(I)におけるXと同じである。)
 また、本発明に係る中間体化合物において、Aは窒素原子であることが好ましい。
(In the general formula (II) and (IIa), R 1, Y 2, m and A are the same as R 1, Y 2, m and A in each of the above general formula (I) and (Ia). General In the formula (II), X is the same as X in the general formula (I).)
In the intermediate compound according to the present invention, A is preferably a nitrogen atom.
 本発明に係るアゾール誘導体の製造方法は、上述のアゾール誘導体の製造方法であって、
 下記一般式(II)または(IIa)で示される中間体化合物をハロゲン酸と反応させて、上記一般式(I)または(Ia)で示されるアゾール誘導体を得る工程を含む構成である。
The method for producing an azole derivative according to the present invention is a method for producing the above azole derivative,
The composition includes a step of reacting an intermediate compound represented by the following general formula (II) or (IIa) with a halogen acid to obtain an azole derivative represented by the above general formula (I) or (Ia).
Figure JPOXMLDOC01-appb-C000026
Figure JPOXMLDOC01-appb-C000026
(一般式(II)および(IIa)中、R、Y、mおよびAは、それぞれ上記一般式(I)におけるR、Y、mおよびAと同じである。一般式(II)中、Xは、上記一般式(I)におけるXと同じである。)
 また、本発明に係るアゾール誘導体の製造方法は、下記一般式(III)で示される化合物を硫黄と反応させ、下記一般式(IIa)で示される化合物または下記一般式(IIb)で示される化合物を得る工程を含むことが好ましい。
(In General Formulas (II) and (IIa), R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in General Formula (I), respectively. General Formula (II) In the formula, X is the same as X in the general formula (I).)
Moreover, the manufacturing method of the azole derivative which concerns on this invention makes the compound shown by the following general formula (III) react with sulfur, the compound shown by the following general formula (IIa), or the compound shown by the following general formula (IIb) It is preferable to include the process of obtaining.
Figure JPOXMLDOC01-appb-C000027
Figure JPOXMLDOC01-appb-C000027
(一般式(III)中、R、Y、mおよびAは、それぞれ上記一般式(I)におけるR、Y、mおよびAと同じである。) (In general formula (III), R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in general formula (I), respectively.)
Figure JPOXMLDOC01-appb-C000028
Figure JPOXMLDOC01-appb-C000028
(一般式(IIa)中、R、Y、mおよびAは、それぞれ上記一般式(I)におけるR、Y、mおよびAと同じである。) (In the general formula (IIa), R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in the general formula (I), respectively.)
Figure JPOXMLDOC01-appb-C000029
Figure JPOXMLDOC01-appb-C000029
(一般式(IIb)中、R、Y、mおよびAは、それぞれ上記一般式(I)におけるR、Y、mおよびAと同じである。)
 また、本発明は、上述のアゾール誘導体を有効成分として含有することを特徴とする農園芸用薬剤または工業用材料保護剤も包含する。
(In the general formula (IIb), R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in the general formula (I), respectively.)
Moreover, this invention also includes the agricultural and horticultural chemical | medical agent or industrial material protecting agent characterized by containing the above-mentioned azole derivative as an active ingredient.
 以下に実施例を示し、本発明の実施の形態についてさらに詳しく説明する。もちろん、本発明は以下の実施例に限定されるものではなく、細部については様々な態様が可能であることはいうまでもない。さらに、本発明は上述した実施形態に限定されるものではなく、請求項に示した範囲で種々の変更が可能であり、それぞれ開示された技術的手段を適宜組み合わせて得られる実施形態についても本発明の技術的範囲に含まれる。また、本明細書中に記載された文献の全てが参考として援用される。 Examples will be shown below, and the embodiments of the present invention will be described in more detail. Of course, the present invention is not limited to the following examples, and it goes without saying that various aspects are possible in detail. Further, the present invention is not limited to the above-described embodiments, and various modifications can be made within the scope shown in the claims, and the present invention is also applied to the embodiments obtained by appropriately combining the disclosed technical means. It is included in the technical scope of the invention. Moreover, all the literatures described in this specification are used as reference.
 <製造例:2-[(5-(4-クロロベンジル)-2-クロロメチル-1-ヒドロキシ-2-メチルシクロペンチル)メチル]-2,4-ジヒドロ-3H-1,2,4-トリアゾール-3-チオン(化合物(1))の合成> <Production Example: 2-[(5- (4-Chlorobenzyl) -2-chloromethyl-1-hydroxy-2-methylcyclopentyl) methyl] -2,4-dihydro-3H-1,2,4-triazole- Synthesis of 3-thione (compound (1))>
Figure JPOXMLDOC01-appb-C000030
Figure JPOXMLDOC01-appb-C000030
 (1)2-[(4-(4-クロロベンジル)-1-メチル-6-オキサ-ビシクロ[3.2.0]ヘプト-5-イル)メチル]-2,4-ジヒドロ-3H-1,2,4-トリアゾール-3-チオン(化合物(2))の合成
 1-[(4-(4-クロロベンジル)-1-メチル-6-オキサ-ビシクロ[3,2,0]ヘプト-5-イル)メチル]-1H-1,2,4-トリアゾール(化合物(3))504.0mg(1.59mmol)を1mlのジメチルホルムアミドに溶解し、そこに粉末硫黄506.2mg(15.8mmol;10eq.)を加え、6時間加熱還流した。室温まで冷却した後、反応液をろ過して不溶物を除き、ろ液を減圧乾固した。残渣にトルエンと10%水酸化ナトリウム水溶液とを加え、析出した桃色の固体をろ過し、トルエンで洗浄した。この固体に1M硫酸水溶液、および酢酸エチルを加え、有機層を分取した。この有機層を水および飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥した。溶媒を留去し、残渣をシリカゲルカラムクロマトグラフィー(Silicagel 60, 230-400 mesh, Merck,酢酸エチル/ヘキサン=1/1)で精製することにより、化合物(2)を淡桃色固体として226mg得た(収率40.7%)。
1H-NMR (CDCl3)
 1.24-1.38(m, 1H), 1.38(s, 3H), 1.60-1.87(m, 3H), 1.97-2.05(m, 1H), 2.48(dd, 1H, J=13.4, 10.6Hz), 2.54(dd, 1H, J=13.4, 4.2Hz), 4.25(d, 1H, J=6.0Hz), 4.37(dd, 1H, J=5.9, 0.9Hz), 4.63(dd, 2H, J=16.2, 14.6Hz), 7.10(d, 2H, J=8.4Hz), 7.16(d, 2H, J=8.4Hz), 7.81(s, 1H), 12.13(s, 1H).
 (2)化合物(1)の合成
 得られた化合物(2)100.5mg(0.287mmol)を1mlのジメチルホルムアミドに溶解し、そこに塩化リチウム145.5mg(3.43mmol;12eq.)、およびp-トルエンスルホン酸一水和物65.9mg(0.346mmol;1.2eq.)を加え、80℃で3.5時間攪拌した。室温まで冷却した後、水、および酢酸エチルを加え、有機層を分取した。この有機層を水および飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥した。溶媒を留去し、残渣をシリカゲルカラムクロマトグラフィー(Silicagel 60, 230-400 mesh, Merck, 酢酸エチル/ヘキサン=2/1)で精製することにより、化合物(1)を白色固体として103.8mg得た(収率93.5%)。融点170-171℃
1H-NMR (CDCl3)
 1.25(s, 3H), 1.38-1.47(m, 2H), 1.63-1.73(m, 1H), 1.87-1.95(m, 1H), 2.33-2.46(m, 2H), 2.50-2.58(m, 1H), 3.65(dd, 2H, J=15.3, 10.7Hz), 4.00(s, 1H), 4.54(t, 2H, J=15.1Hz), 7.11(d, 2H, J=8.4Hz), 7.21(d, 2H, J=8.4Hz), 7.84(s, 1H), 11.9(s, 1H).
 LC-MS
 (M+H+) 386
 <参考製造例:1-[(4-(4-クロロベンジル)-1-メトキシメチル-6-オキサ-ビシクロ[3,2,0]ヘプト-5-イル)メチル]-1H-1,2,4-トリアゾール(アゾール誘導体(IIIa)の一態様、以下、アゾール誘導体(3a))の合成>
 (1)1-[(4-(4-クロロベンジル)-1-ヒドロキシメチル-6-オキサ-ビシクロ[3,2,0]ヘプト-5-イル)メチル]-1H-1,2,4-トリアゾール(アゾール誘導体(VI)の一態様、以下、アゾール誘導体(6))の合成
 1-[(5-(4-クロロベンジル)-1-ヒドロキシ-2,2-ビスヒドロキシメチルシクロペンチル)メチル]-1H-1,2,4-トリアゾール(アゾール誘導体(VII)の一態様)30.0mg(0.0853mmol)をTHF0.9mlに溶解し、氷浴で0℃に冷却した。この溶液に水素化ナトリウム8.2mg(0.205mmol)を加え、0℃で10分間撹拌した。さらにp-トルエンスルホニルクロライド16.2mg(0.0853mmol)を加え、室温まで戻しながら2.5時間撹拌した。反応終了後、水を加え、酢酸エチルで抽出した。有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥した。溶媒を留去し、残渣をシリカゲルカラムクロマトグラフィー(クロロホルム/メタノール=30/1)によって精製し、アゾール誘導体(6)を得た。
収量:20.4mg、収率:71.6%、性状:無色液体
1H-NMR(CDCl3)
 1.46-1.58(m, 2H), 1.79-1.96(m, 3H), 2.61(dd, 1H, J=13.7, 8.3Hz), 2.67(dd, 1H, J=13.7, 6.4Hz), 3.45(dd, 1H, J=12.9, 9.6Hz), 3.94(dd, 1H, J=12.9, 3.1Hz), 4.14(d, 1H, J=6.3Hz), 4.19(d, 1H, J=6.3Hz), 4.22(d, 1H, J=15.0Hz), 4.57(dd, 1H, J=9.6, 3.1Hz), 4.68(d, 1H, J=15.0Hz), 7.01(d, 2H, J=8.4Hz), 7.25(d, 2H, J=8.4Hz), 7.70(s, 1H), 7.97(s, 1H).
 (2)アゾール誘導体(3a)の合成
 アゾール誘導体(6)50.0mgをTHF1.5mlに溶解し、水素化ナトリウム7.2mg(0.180mmol)を加え、室温で15分間撹拌した。ここにヨードメタン0.0112ml(0.180mmol)を加え、室温で1時間撹拌した後、50℃で3時間撹拌した。さらにヨードメタン0.0112mlを加えて同温度で5時間撹拌した後、ヨードメタン0.0112mlおよび水素化ナトリウム7.2mgを加えて室温で15時間し、さらに50℃で4時間撹拌し、さらにヨードメタン0.0112mlおよび水素化ナトリウム7.2mgを加えて1.5時間撹拌した。反応終了後、水を加え、酢酸エチルで抽出し、飽和食塩水で洗浄した。有機層を無水硫酸ナトリウムで乾燥した後、溶媒を留去し、残渣をシリカゲルカラムクロマトグラフィー(酢酸エチル/ヘキサン=1/3)によって精製し、アゾール誘導体(3a)を得た。
収量:42.4mg、収率:81.3%、性状:無色粘稠液体
1H-NMR(CDCl3)
 1.45-1.53(m, 1H), 1.57-1.64(m, 1H), 1.68-1.76(m, 1H), 1.81-1.94(m, 2H), 2.33(dd, 1H, J=13.5, 4.0Hz), 2.45(dd, 1H, J=13.5, 9.6Hz), 3.34(d, 1H, J=10.1Hz), 3.38(s, 3H), 3.39(d, 1H, J=10.1Hz), 4.14(d, 1H, J=6.1Hz), 4.48(dd, 1H, J=6.1, 1.3Hz), 4.53(d, 1H, J=14.8Hz), 4.73(d, 1H, J=14.8Hz), 7.05(d, 2H, J=8.4Hz), 7.21(d, 2H, J=8.4Hz), 7.96(s, 1H), 8.16(s, 1H).
 <製剤例>
 合成した化合物(1)を用いて水和剤、粉剤、粒剤および乳剤を製剤した。
(1) 2-[(4- (4-Chlorobenzyl) -1-methyl-6-oxa-bicyclo [3.2.0] hept-5-yl) methyl] -2,4-dihydro-3H-1 , 2,4-Triazole-3-thione (Compound (2)) 1-[(4- (4-Chlorobenzyl) -1-methyl-6-oxa-bicyclo [3,2,0] hept-5 -Yl) methyl] -1H-1,2,4-triazole (compound (3)) 504.0 mg (1.59 mmol) was dissolved in 1 ml of dimethylformamide, where 506.2 mg (15.8 mmol) of powdered sulfur was dissolved; 10 eq.) Was added and heated to reflux for 6 hours. After cooling to room temperature, the reaction solution was filtered to remove insolubles, and the filtrate was dried under reduced pressure. Toluene and 10% aqueous sodium hydroxide solution were added to the residue, and the precipitated pink solid was filtered and washed with toluene. A 1M sulfuric acid aqueous solution and ethyl acetate were added to the solid, and the organic layer was separated. This organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off, and the residue was purified by silica gel column chromatography (Silicagel 60, 230-400 mesh, Merck, ethyl acetate / hexane = 1/1) to obtain 226 mg of compound (2) as a pale pink solid. (Yield 40.7%).
1 H-NMR (CDCl 3 )
1.24-1.38 (m, 1H), 1.38 (s, 3H), 1.60-1.87 (m, 3H), 1.97-2.05 (m, 1H), 2.48 (dd, 1H, J = 13.4, 10.6Hz), 2.54 ( dd, 1H, J = 13.4, 4.2Hz), 4.25 (d, 1H, J = 6.0Hz), 4.37 (dd, 1H, J = 5.9, 0.9Hz), 4.63 (dd, 2H, J = 16.2, 14.6Hz ), 7.10 (d, 2H, J = 8.4Hz), 7.16 (d, 2H, J = 8.4Hz), 7.81 (s, 1H), 12.13 (s, 1H).
(2) Synthesis of compound (1) 100.5 mg (0.287 mmol) of the obtained compound (2) was dissolved in 1 ml of dimethylformamide, 145.5 mg (3.43 mmol; 12 eq.) Of lithium chloride, and 65.9 mg (0.346 mmol; 1.2 eq.) of p-toluenesulfonic acid monohydrate was added, and the mixture was stirred at 80 ° C. for 3.5 hours. After cooling to room temperature, water and ethyl acetate were added, and the organic layer was separated. This organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off, and the residue was purified by silica gel column chromatography (Silicagel 60, 230-400 mesh, Merck, ethyl acetate / hexane = 2/1) to obtain 103.8 mg of compound (1) as a white solid. (Yield 93.5%). Melting point 170-171 ° C
1 H-NMR (CDCl 3 )
1.25 (s, 3H), 1.38-1.47 (m, 2H), 1.63-1.73 (m, 1H), 1.87-1.95 (m, 1H), 2.33-2.46 (m, 2H), 2.50-2.58 (m, 1H ), 3.65 (dd, 2H, J = 15.3, 10.7Hz), 4.00 (s, 1H), 4.54 (t, 2H, J = 15.1Hz), 7.11 (d, 2H, J = 8.4Hz), 7.21 (d , 2H, J = 8.4Hz), 7.84 (s, 1H), 11.9 (s, 1H).
LC-MS
(M + H + ) 386
<Reference Production Example: 1-[(4- (4-Chlorobenzyl) -1-methoxymethyl-6-oxa-bicyclo [3,2,0] hept-5-yl) methyl] -1H-1,2, Synthesis of 4-triazole (one embodiment of azole derivative (IIIa), hereinafter azole derivative (3a))>
(1) 1-[(4- (4-Chlorobenzyl) -1-hydroxymethyl-6-oxa-bicyclo [3,2,0] hept-5-yl) methyl] -1H-1,2,4- Synthesis of triazole (one embodiment of azole derivative (VI), hereinafter azole derivative (6)) 1-[(5- (4-chlorobenzyl) -1-hydroxy-2,2-bishydroxymethylcyclopentyl) methyl]- 30.0 mg (0.0853 mmol) of 1H-1,2,4-triazole (one embodiment of azole derivative (VII)) was dissolved in 0.9 ml of THF, and cooled to 0 ° C. in an ice bath. To this solution, 8.2 mg (0.205 mmol) of sodium hydride was added and stirred at 0 ° C. for 10 minutes. Further, 16.2 mg (0.0853 mmol) of p-toluenesulfonyl chloride was added and stirred for 2.5 hours while returning to room temperature. After completion of the reaction, water was added and extracted with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was distilled off, and the residue was purified by silica gel column chromatography (chloroform / methanol = 30/1) to obtain an azole derivative (6).
Yield: 20.4 mg, Yield: 71.6%, Property: colorless liquid
1 H-NMR (CDCl 3 )
1.46-1.58 (m, 2H), 1.79-1.96 (m, 3H), 2.61 (dd, 1H, J = 13.7, 8.3Hz), 2.67 (dd, 1H, J = 13.7, 6.4Hz), 3.45 (dd, 1H, J = 12.9, 9.6Hz), 3.94 (dd, 1H, J = 12.9, 3.1Hz), 4.14 (d, 1H, J = 6.3Hz), 4.19 (d, 1H, J = 6.3Hz), 4.22 ( d, 1H, J = 15.0Hz), 4.57 (dd, 1H, J = 9.6, 3.1Hz), 4.68 (d, 1H, J = 15.0Hz), 7.01 (d, 2H, J = 8.4Hz), 7.25 ( d, 2H, J = 8.4Hz), 7.70 (s, 1H), 7.97 (s, 1H).
(2) Synthesis of azole derivative (3a) 50.0 mg of azole derivative (6) was dissolved in 1.5 ml of THF, 7.2 mg (0.180 mmol) of sodium hydride was added, and the mixture was stirred at room temperature for 15 minutes. To this was added 0.0112 ml (0.180 mmol) of iodomethane, and the mixture was stirred at room temperature for 1 hour and then stirred at 50 ° C. for 3 hours. Further, 0.0112 ml of iodomethane was added and stirred at the same temperature for 5 hours, 0.0112 ml of iodomethane and 7.2 mg of sodium hydride were added, and the mixture was stirred at room temperature for 15 hours, further stirred at 50 ° C. for 4 hours, and further, iodomethane was added in 0.1. 0112 ml and sodium hydride 7.2 mg were added and stirred for 1.5 hours. After completion of the reaction, water was added, extracted with ethyl acetate, and washed with saturated brine. The organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off, and the residue was purified by silica gel column chromatography (ethyl acetate / hexane = 1/3) to obtain the azole derivative (3a).
Yield: 42.4 mg, Yield: 81.3%, Property: colorless viscous liquid
1 H-NMR (CDCl 3 )
1.45-1.53 (m, 1H), 1.57-1.64 (m, 1H), 1.68-1.76 (m, 1H), 1.81-1.94 (m, 2H), 2.33 (dd, 1H, J = 13.5, 4.0Hz), 2.45 (dd, 1H, J = 13.5, 9.6Hz), 3.34 (d, 1H, J = 10.1Hz), 3.38 (s, 3H), 3.39 (d, 1H, J = 10.1Hz), 4.14 (d, 1H , J = 6.1Hz), 4.48 (dd, 1H, J = 6.1, 1.3Hz), 4.53 (d, 1H, J = 14.8Hz), 4.73 (d, 1H, J = 14.8Hz), 7.05 (d, 2H , J = 8.4Hz), 7.21 (d, 2H, J = 8.4Hz), 7.96 (s, 1H), 8.16 (s, 1H).
<Formulation example>
Using the synthesized compound (1), wettable powder, powder, granule and emulsion were prepared.
 (水和剤)
化合物(1)      50 部
リグニンスルホン酸塩   5 部
アルキルスルホン酸塩   3 部
珪藻土         42 部
を粉砕混合して水和剤とし、水で希釈して使用した。
(Wettable powder)
Compound (1) 50 parts lignin sulfonate 5 parts alkyl sulfonate 3 parts diatomaceous earth 42 parts were pulverized and mixed to obtain a wettable powder and diluted with water for use.
 (粉剤)
化合物(1)     3 部
クレー       40 部
タルク       57 部
を粉砕混合し、散粉として使用する粉剤とした。
(Powder)
Compound (1) 3 parts Clay 40 parts Talc 57 parts were pulverized and mixed to prepare a powder used as dust.
 (粒剤)
化合物(1)       5 部
ベンナイト       43 部
クレー         45 部
リグニンスルホン酸塩   7 部
を均一に混合しさらに水を加えて練り合わせ、押し出し式造粒機で粒状に加工乾燥して粒剤とした。
(Granule)
Compound (1) 5 parts Bennite 43 parts Clay 45 parts Lignin sulfonate 7 parts were mixed uniformly, water was added and kneaded, and processed and dried into granules with an extrusion granulator to give granules.
 (乳剤)
化合物(1)                20 部
ポリオキシエチレンアルキルアリールエーテル 10 部
ポリオキシエチレンソルビタンモノラウレート  3 部
キシレン                  67 部
を均一に混合溶解して乳剤とした。
(emulsion)
Compound (1) 20 parts polyoxyethylene alkyl aryl ether 10 parts polyoxyethylene sorbitan monolaurate 3 parts xylene 67 parts were mixed and dissolved uniformly to prepare an emulsion.
 <試験例1:茎葉散布処理によるキュウリ灰色かび病防除効果試験>
 角型プラスチックポット(6cm×6cm)を用いて栽培した子葉期のキュウリ(品種:SHARP1)に、上述の製剤例に示すような化合物(1)の水和剤形態のものを、水で所定濃度(100mg/L)に希釈懸濁し、1,000L/haの割合で散布した。散布葉を風乾した後、灰色かび病菌の胞子液をしみこませたペーパーディスク(直径8mm)を乗せ、20℃高湿度条件下に保った。接種から5日後にキュウリ灰色かび病の罹病度を表1に示す調査基準に基づき調査して、防除価を下記式により算出した。
防除価(%)=(1-(散布区の平均罹病度/無散布区の平均罹病度))×100
<Test Example 1: Cucumber gray mold control effect test by foliar spray treatment>
A hydrated form of compound (1) as shown in the above formulation example in a cotyledon stage cucumber (variety: SHARP1) cultivated using a square plastic pot (6 cm × 6 cm) with water at a predetermined concentration (100 mg / L) was diluted and suspended at a rate of 1,000 L / ha. The sprayed leaves were air-dried and then placed on a paper disk (diameter 8 mm) soaked with a spore solution of gray mold fungus and kept at 20 ° C. under high humidity. Five days after the inoculation, the morbidity of cucumber gray mold was investigated based on the survey criteria shown in Table 1, and the control value was calculated by the following formula.
Control value (%) = (1− (average morbidity in sprayed area / average illness in non-sprayed area)) × 100
Figure JPOXMLDOC01-appb-T000031
Figure JPOXMLDOC01-appb-T000031
 その結果、防除価は90%以上であった。 As a result, the control value was 90% or more.
 <試験例2:茎葉散布処理によるコムギ赤さび病防除効果試験>
 角型プラスチックポット(6cm×6cm)を用いて栽培した第2葉期のコムギ(品種:農林61号)に、製剤例1のような化合物(1)の水和剤形態のものを、水で所定濃度(12.5mg/L)に希釈懸濁し、1,000L/haの割合で散布した。散布葉を風乾した後、コムギ赤さび病菌の胞子(200個/視野に調整、終濃度60ppmとなるようにグラミンSを添加)を噴霧接種し、25℃高湿度条件下に48時間保った。その後は温室内で管理した。接種後11日目にコムギ赤さび病の罹病度を表2に示す調査基準に基づき調査して、防除価を下記式により算出した。
防除価(%)=(1-(散布区の平均罹病度/無散布区の平均罹病度))×100
<Test Example 2: Wheat red rust control effect test by foliar spray treatment>
In a second leaf stage wheat (cultivar: Norin 61) grown using a square plastic pot (6 cm × 6 cm), a compound (1) in the form of a wettable powder as in Formulation Example 1 is washed with water. The suspension was diluted to a predetermined concentration (12.5 mg / L) and sprayed at a rate of 1,000 L / ha. The sprayed leaves were air-dried and then spray-inoculated with spores of wheat red rust fungus (adjusted to 200 cells / field of view, added with Grameen S to a final concentration of 60 ppm), and kept at 25 ° C. under high humidity for 48 hours. After that, it was managed in the greenhouse. On the 11th day after the inoculation, the morbidity of wheat rust was investigated based on the survey criteria shown in Table 2, and the control value was calculated by the following formula.
Control value (%) = (1− (average morbidity in sprayed area / average illness in non-sprayed area)) × 100
Figure JPOXMLDOC01-appb-T000032
Figure JPOXMLDOC01-appb-T000032
 その結果、防除価は90%以上であった。 As a result, the control value was 90% or more.
 <試験例3:コムギ種子に対する種子処理による生育抑制の薬害評価試験>
 ポット試験により、種子処理による生育抑制の薬害を評価した。処理量が20または200g ai/100kg seedsとなるようにDMSOに溶解した化合物(1)をバイアル内でコムギ種子(品種:農林61号)に塗沫した後、8粒のコムギ種子を80cmポットに播種した。温室内で下部給水管理し、播種15日後にコムギの草丈を調査した。なお、対照としては、化合物(1)の代わりに、下記式(IX)で示される化合物(9)およびメトコナゾールを用いて、あるいは何ら薬剤を用いずに試験を行った。結果を表3に示す。
<Test Example 3: Evaluation test for phytotoxicity of wheat growth suppression by seed treatment>
By pot test, the phytotoxicity of growth suppression by seed treatment was evaluated. After the compound (1) dissolved in DMSO so that the treatment amount is 20 or 200 g ai / 100 kg seeds is smeared on the wheat seeds (variety: Norin 61) in a vial, 8 wheat seeds in 80 cm 2 pots Sowing. The lower water supply was controlled in a greenhouse, and the plant height of wheat was investigated 15 days after sowing. As a control, a test was conducted using the compound (9) represented by the following formula (IX) and metconazole instead of the compound (1) or without using any drug. The results are shown in Table 3.
Figure JPOXMLDOC01-appb-C000033
Figure JPOXMLDOC01-appb-C000033
Figure JPOXMLDOC01-appb-T000034
Figure JPOXMLDOC01-appb-T000034
 さらに、ネクロシスについて観察を行ったところ、化合物(9)を用いた場合には、何れの処理量においても植物体において軽微なネクロシスが観察された。また、200g ai/100kg seedsの処理量のメトコナゾールを用いた場合には、植物体において軽微なネクロシスが観察された、一方、化合物(1)を用いた場合には、何れの処理量においてもネクロシスは観察されなかった。 Further, when the necrosis was observed, slight necrosis was observed in the plant body at any treatment amount when the compound (9) was used. In addition, when using metconazole at a treatment amount of 200 g ai / 100 kg seeds, slight necrosis was observed in the plant body, whereas when using compound (1), necrosis was observed at any treatment amount. Was not observed.
 <試験例4:ダイズに対する生育抑制の薬害評価試験>
 ポット試験により、茎葉散布処理による生育抑制の薬害を評価した。角型プラスチックポット(6cm×6cm)を用いて栽培したダイズ(品種:エンレイ)に、製剤例1のような化合物(1)の水和剤形態のものを、水で所定濃度(500mg/L)に希釈懸濁し、1000L/haの割合で散布した。散布葉を風乾し、温室内で管理した。薬剤散布後13日目にダイズの草丈を計測した。なお、対照としては、化合物(1)の代わりに化合物(9)を用いて、あるいは何ら薬剤を用いずに試験を行った。結果を表4に示す。
<Test Example 4: Test for evaluating phytotoxicity of growth inhibition for soybean>
The pot test evaluated the phytotoxicity of growth inhibition by foliar spray treatment. A soybean (cultivar: Enrei) cultivated using a square plastic pot (6 cm x 6 cm), a compound (1) in the form of a wettable powder as in Formulation Example 1, with water at a predetermined concentration (500 mg / L) Diluted and suspended at a rate of 1000 L / ha. The sprayed leaves were air-dried and managed in a greenhouse. The plant height of soybean was measured on the 13th day after the spraying of the drug. As a control, the test was performed using compound (9) instead of compound (1) or without using any drug. The results are shown in Table 4.
Figure JPOXMLDOC01-appb-T000035
Figure JPOXMLDOC01-appb-T000035
 <試験例5:キュウリに対する生育抑制の薬害評価試験>
 ポット試験により、茎葉散布処理による生育抑制の薬害を評価した。角型プラスチックポット(6cm×6cm)を用いて栽培したキュウリ(品種:SHARP1)に、製剤例1のような化合物(1)の水和剤形態のものを、水で所定濃度(1000および500mg/L)に希釈懸濁し、1000L/haの割合で散布した。散布葉を風乾し、温室内で管理した。薬剤散布後11日目にキュウリの第二節間長を計測した。なお対照としては、化合物(1)の代わりに化合物(9)およびメトコナゾールを用いて、あるいは何ら薬剤を用いずに試験を行った。結果を表5に示す。
<Test Example 5: Evaluation of phytotoxicity for growth inhibition against cucumber>
The pot test evaluated the phytotoxicity of growth inhibition by foliar spray treatment. To a cucumber (variety: SHARP1) cultivated using a square plastic pot (6 cm × 6 cm), a compound (1) in the form of a wettable powder as in Formulation Example 1 was added with water at a predetermined concentration (1000 and 500 mg / day). L) was diluted and suspended and sprayed at a rate of 1000 L / ha. The sprayed leaves were air-dried and managed in a greenhouse. The second internode length of the cucumber was measured on the 11th day after the drug application. As a control, the test was conducted using compound (9) and metconazole instead of compound (1) or without using any drug. The results are shown in Table 5.
Figure JPOXMLDOC01-appb-T000036
Figure JPOXMLDOC01-appb-T000036
 <試験例6:病原菌に対する抗菌性試験>
 本試験例では、各種植物病原性糸状菌に対する抗菌性を試験した。
<Test Example 6: Antibacterial test against pathogenic bacteria>
In this test example, antibacterial properties against various phytopathogenic fungi were tested.
 化合物(1)をジメチルスルホキシドに溶解し、60℃前後のPDA培地(ポテト-デキストロース-アガー培地)に加えた。三角フラスコ内でよく混合した後、シャーレ内に流し固化させて、所定の濃度(5mg/L)で化合物(1)を含む平板培地を作製した。 Compound (1) was dissolved in dimethyl sulfoxide and added to PDA medium (potato-dextrose-aggar medium) at around 60 ° C. After mixing well in an Erlenmeyer flask, it was poured into a petri dish and solidified to prepare a plate medium containing the compound (1) at a predetermined concentration (5 mg / L).
 一方、予め平板培地上で培養した供試菌(オオムギ斑葉病菌(Pyrenophora graminea)、スクレロチニア(菌核病菌)(Sclerotinia sclerotiorum)、または灰色かび病菌(Botrytis cinerea))を直径4mmのコルクボーラーで打ち抜き,上記の薬剤含有平板培地上に接種した。接種後、各菌の生育適温(例えば、LIST OF CULTURES 1996 microorganisms 10th edition、財団法人発酵研究所等の文献を参照)にて1~14日間培養し、菌の生育を菌そう直径で測定した。薬剤含有平板培地上で得られた菌の生育程度を、薬剤無添加区における菌の生育程度と比較して、下記式により菌糸伸長抑制率を求めた。なお、下記式中、Rは菌糸伸長抑制率(%)、dcは無処理平板上菌そう直径、dtは薬剤処理平板上菌そう直径を示している。
R=100(dc-dt)/dc
 その結果、菌糸伸長抑制率Rは何れの菌に対しても80%以上であった。
On the other hand, test bacteria (Pyrenophora graminea, Sclerotinia sclerotiorum, or Botrytis cinerea) previously cultured on a plate medium are punched out with a cork borer with a diameter of 4 mm. , Inoculated on the above-mentioned drug-containing plate medium. After inoculation, each fungus was cultured at an appropriate temperature for growth (for example, LIST OF CULTURES 1996 microorganisms 10th edition, refer to the literature of Foundation for Fermentation, etc.) for 1 to 14 days, and the growth of the fungus was measured by the fungus diameter. The growth degree of the bacteria obtained on the drug-containing plate medium was compared with the growth degree of the bacteria in the drug-free group, and the mycelial elongation suppression rate was determined by the following formula. In the following formula, R represents the hyphal elongation inhibition rate (%), dc represents the diameter of the fungus on the untreated plate, and dt represents the diameter of the fungus on the drug-treated plate.
R = 100 (dc−dt) / dc
As a result, the mycelial elongation suppression rate R was 80% or more for all the bacteria.
 本発明は、植物に対する薬害が最小限に抑えられ、植物病害を防除できる防除剤の有効成分として好適に利用することができる。 The present invention can be suitably used as an active ingredient of a control agent that can minimize plant phytotoxicity and can control plant diseases.

Claims (10)

  1.  下記一般式(I)または(Ia)で示されることを特徴とするアゾール誘導体。
    Figure JPOXMLDOC01-appb-C000001
    (一般式(I)および(Ia)中、Yは、ハロゲン原子を表し、
    は、炭素数1~3のアルキル基、炭素数1~3のアルコキシ基または水素原子を表し、
    は、ハロゲン原子を表し、mは、0、1または2を表し、mが2である場合には、複数あるYは互いに異なっていてもよく、
    Aは、窒素原子またはメチン基を表す。
    一般式(I)中、Xは、-SH、-SR、-SO-R、-SO-Rまたは-SOHを表す。Rは、炭素原子数1~6のアルキル基、炭素原子数2~6のアルケニル基、炭素原子数1~6のハロアルキル基、炭素原子数2~6のハロアルケニル基、アリール基またはアリールアルキル基(アルキル部分の炭素原子数が1~4)であり、Rにおける上記アリール基およびアリールアルキル基は、芳香環における少なくとも1つの水素原子がハロゲン原子、炭素数1~4のアルキル基(シクロアルキル基を含む)、または炭素数1~4のハロアルキル基で置換されていてもよい。)
    An azole derivative represented by the following general formula (I) or (Ia):
    Figure JPOXMLDOC01-appb-C000001
    (In the general formulas (I) and (Ia), Y 1 represents a halogen atom,
    R 1 represents an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, or a hydrogen atom,
    Y 2 represents a halogen atom, m represents 0, 1 or 2, and when m is 2, a plurality of Y 2 may be different from each other;
    A represents a nitrogen atom or a methine group.
    In the general formula (I), X represents —SH, —SR 2 , —SO—R 2 , —SO 2 —R 2 or —SO 3 H. R 2 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a haloalkyl group having 1 to 6 carbon atoms, a haloalkenyl group having 2 to 6 carbon atoms, an aryl group, or an arylalkyl A group (the alkyl part has 1 to 4 carbon atoms), and in the aryl group and arylalkyl group in R 2 , at least one hydrogen atom in the aromatic ring is a halogen atom, and an alkyl group having 1 to 4 carbon atoms (cyclohexane). An alkyl group), or a haloalkyl group having 1 to 4 carbon atoms. )
  2.  Yは塩素原子であることを特徴とする請求項1に記載のアゾール誘導体。 The azole derivative according to claim 1, wherein Y 1 is a chlorine atom.
  3.  下記一般式(Ic)または(Id)で示されることを特徴とする請求項1または2に記載のアゾール誘導体。
    Figure JPOXMLDOC01-appb-C000002
    (一般式(Ic)および(Id)中、R、Y、YおよびAは、それぞれ上記一般式(I)および(Ib)におけるR、Y、YおよびAと同じである。一般式(Ic)中、Xは、上記一般式(I)におけるXと同じである。)
    The azole derivative according to claim 1 or 2, which is represented by the following general formula (Ic) or (Id).
    Figure JPOXMLDOC01-appb-C000002
    (In the general formula (Ic) and (Id), R 1, Y 1, Y 2 and A are the same as R 1, Y 1, Y 2 and A in each of the above general formula (I) and (Ib) In general formula (Ic), X is the same as X in general formula (I) above.)
  4.  Aは窒素原子であることを特徴とする請求項1~3の何れか1項に記載のアゾール誘導体。 The azole derivative according to any one of claims 1 to 3, wherein A is a nitrogen atom.
  5.  下記一般式(Ie)で示されることを特徴とする請求項1~4の何れか1項に記載のアゾール誘導体。
    Figure JPOXMLDOC01-appb-C000003
    (一般式(Ic)中、Yは、水素原子、フッ素原子または塩素原子を表す。)
    The azole derivative according to any one of claims 1 to 4, which is represented by the following general formula (Ie):
    Figure JPOXMLDOC01-appb-C000003
    (In the general formula (Ic), Y 3 represents a hydrogen atom, a fluorine atom or a chlorine atom.)
  6.  請求項1に記載のアゾール誘導体を製造するために用いられる中間体化合物であって、下記一般式(II)または(IIa)で示されることを特徴とする中間体化合物。
    Figure JPOXMLDOC01-appb-C000004
    (一般式(II)および(IIa)中、R、Y、mおよびAは、それぞれ上記一般式(I)および(Ia)におけるR、Y、mおよびAと同じである。一般式(II)中、Xは、上記一般式(I)におけるXと同じである。)
    An intermediate compound used for producing the azole derivative according to claim 1, wherein the intermediate compound is represented by the following general formula (II) or (IIa).
    Figure JPOXMLDOC01-appb-C000004
    (In the general formula (II) and (IIa), R 1, Y 2, m and A are the same as R 1, Y 2, m and A in each of the above general formula (I) and (Ia). General In the formula (II), X is the same as X in the general formula (I).)
  7.  Aは窒素原子であることを特徴とする請求項6に記載の中間体化合物。 The intermediate compound according to claim 6, wherein A is a nitrogen atom.
  8.  請求項1~5の何れか1項に記載のアゾール誘導体の製造方法であって、
     下記一般式(II)または(IIa)で示される中間体化合物をハロゲン酸と反応させて、上記一般式(I)または(Ia)で示されるアゾール誘導体を得る工程を含むことを特徴とするアゾール誘導体の製造方法。
    Figure JPOXMLDOC01-appb-C000005
    (一般式(II)および(IIa)中、R、Y、mおよびAは、それぞれ上記一般式(I)におけるR、Y、mおよびAと同じである。一般式(II)中、Xは、上記一般式(I)におけるXと同じである。)
    A process for producing the azole derivative according to any one of claims 1 to 5,
    An azole comprising a step of reacting an intermediate compound represented by the following general formula (II) or (IIa) with a halogen acid to obtain an azole derivative represented by the above general formula (I) or (Ia) A method for producing a derivative.
    Figure JPOXMLDOC01-appb-C000005
    (In General Formulas (II) and (IIa), R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in General Formula (I), respectively. General Formula (II) In the formula, X is the same as X in the general formula (I).)
  9.  下記一般式(III)で示される化合物を硫黄と反応させ、下記一般式(IIa)で示される化合物または下記一般式(IIb)で示される化合物を得る工程を含むことを特徴とする請求項8に記載の製造方法。
    Figure JPOXMLDOC01-appb-C000006
    (一般式(III)中、R、Y、mおよびAは、それぞれ上記一般式(I)におけるR、Y、mおよびAと同じである。)
    Figure JPOXMLDOC01-appb-C000007
    (一般式(IIa)中、R、Y、mおよびAは、それぞれ上記一般式(I)におけるR、Y、mおよびAと同じである。)
    Figure JPOXMLDOC01-appb-C000008
    (一般式(IIb)中、R、Y、mおよびAは、それぞれ上記一般式(I)におけるR、Y、mおよびAと同じである。)
    9. A step of reacting a compound represented by the following general formula (III) with sulfur to obtain a compound represented by the following general formula (IIa) or a compound represented by the following general formula (IIb). The manufacturing method as described in.
    Figure JPOXMLDOC01-appb-C000006
    (In general formula (III), R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in general formula (I), respectively.)
    Figure JPOXMLDOC01-appb-C000007
    (In the general formula (IIa), R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in the general formula (I), respectively.)
    Figure JPOXMLDOC01-appb-C000008
    (In the general formula (IIb), R 1 , Y 2 , m and A are the same as R 1 , Y 2 , m and A in the general formula (I), respectively.)
  10.  請求項1~5の何れか1項に記載のアゾール誘導体を有効成分として含有することを特徴とする農園芸用薬剤または工業用材料保護剤。 An agricultural or horticultural agent or an industrial material protective agent comprising the azole derivative according to any one of claims 1 to 5 as an active ingredient.
PCT/JP2012/080751 2011-12-05 2012-11-28 Azole derivative, method for producing azole derivative, intermediate compound, drug for agricultural and horticultural applications, and industrial material protectant WO2013084770A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011266240 2011-12-05
JP2011-266240 2011-12-05

Publications (1)

Publication Number Publication Date
WO2013084770A1 true WO2013084770A1 (en) 2013-06-13

Family

ID=48574140

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2012/080751 WO2013084770A1 (en) 2011-12-05 2012-11-28 Azole derivative, method for producing azole derivative, intermediate compound, drug for agricultural and horticultural applications, and industrial material protectant

Country Status (1)

Country Link
WO (1) WO2013084770A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05201805A (en) * 1992-01-28 1993-08-10 Hodogaya Chem Co Ltd Plant growth regulator composition
JPH06227914A (en) * 1993-01-28 1994-08-16 Sankyo Co Ltd Agricultural/horticultural formula bactericide
WO2010122170A1 (en) * 2009-04-24 2010-10-28 Basf Se 5-mercapto- [1,2,4] triazolylmethyl-cyclopentanol compounds and their agricultural and pharmaceuti al uses
WO2010122169A1 (en) * 2009-04-24 2010-10-28 Basf Se 5-mercapto- [1,2, 4] triazole compounds and their agricultural and pharmaceutical uses
WO2010122167A1 (en) * 2009-04-24 2010-10-28 Basf Se 5 -mercapto- [1, 2, 4] triazolylmethyl-cyclopentanol compounds and their agricultural and pharmaceutical uses
WO2010149414A1 (en) * 2009-04-24 2010-12-29 Basf Se 5-mercapto-[1, 2, 4] triazolylmethyl-cyclopentanol compounds and their agricultural and pharmaceutical uses
WO2011070771A1 (en) * 2009-12-08 2011-06-16 Kureha Corporation Azole derivatives, methods for producing the same, intermediate thereof, agro-horticultural agents

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05201805A (en) * 1992-01-28 1993-08-10 Hodogaya Chem Co Ltd Plant growth regulator composition
JPH06227914A (en) * 1993-01-28 1994-08-16 Sankyo Co Ltd Agricultural/horticultural formula bactericide
WO2010122170A1 (en) * 2009-04-24 2010-10-28 Basf Se 5-mercapto- [1,2,4] triazolylmethyl-cyclopentanol compounds and their agricultural and pharmaceuti al uses
WO2010122169A1 (en) * 2009-04-24 2010-10-28 Basf Se 5-mercapto- [1,2, 4] triazole compounds and their agricultural and pharmaceutical uses
WO2010122167A1 (en) * 2009-04-24 2010-10-28 Basf Se 5 -mercapto- [1, 2, 4] triazolylmethyl-cyclopentanol compounds and their agricultural and pharmaceutical uses
WO2010149414A1 (en) * 2009-04-24 2010-12-29 Basf Se 5-mercapto-[1, 2, 4] triazolylmethyl-cyclopentanol compounds and their agricultural and pharmaceutical uses
WO2011070771A1 (en) * 2009-12-08 2011-06-16 Kureha Corporation Azole derivatives, methods for producing the same, intermediate thereof, agro-horticultural agents

Similar Documents

Publication Publication Date Title
JP5831990B2 (en) Azole derivatives and methods for producing the same, intermediate compounds of the derivatives, and agricultural and horticultural agents
JP5886847B2 (en) Azole derivatives, process for producing the same, intermediate compounds, agricultural and horticultural chemicals and industrial material protecting agents
JP5881733B2 (en) Azole derivatives and uses thereof
KR20110036766A (en) 5-benzyl-4-azolylmethyl-4-spiro[2.4]heptanol derivatives, methods for producing the same, and agro-horticultural agents and industrial material protecting agents thereof
JP2013512857A (en) Azole derivatives and methods for producing the same, intermediate compounds of the derivatives and methods for producing the same, and agricultural and horticultural agents and industrial material protecting agents containing the derivatives
JP5826839B2 (en) Azole derivatives, methods for producing azole derivatives, and intermediate compounds
WO2009088070A1 (en) (heterocyclic methyl)azolylmethylcyclopentanol derivative and intermediate thereof, process for production of the derivative, and agricultural or horticultural preparation and protective agent for industrial material each comprising the derivative
JP5858999B2 (en) Agricultural and horticultural agents, plant disease control compositions, plant disease control methods, and plant disease control products
WO2010074021A1 (en) Substituted 1-(1-chlorocylcopropyl)-2-(1h-1,2,4-triazol-1-yl)-2-propen-1-ol derivative, method for producing same and agricultural/horticultural chemical and industrial material-protecting agent comprising same
WO2021177442A1 (en) Azole derivative, method for producing azole derivative, agent for agricultural and horticultural use, and industrial material protection agent
JP2012219019A (en) Hydroxyisoxazole derivative, and fungicide containing the same
JP5859000B2 (en) Method for producing oxetane compound, method for producing azolylmethylcyclopentanol compound, and intermediate compound
JP2013100238A (en) Triazole derivative, intermediate compound, method for producing triazole derivative, agricultural and horticultural chemical, and industrial material protective agent
WO2013047308A1 (en) Azole derivative, agricultural/horticultural chemical, industrial material protecting agent, method for controlling plant disease, and seed
WO2013084770A1 (en) Azole derivative, method for producing azole derivative, intermediate compound, drug for agricultural and horticultural applications, and industrial material protectant
JP2019031463A (en) Azole derivative and utilization thereof as agricultural and horticultural agent
WO2012169522A1 (en) Agricultural or horticultural chemical agent, method for controlling plant disease, and product for controlling plant disease
JPWO2012165499A1 (en) Triazole compounds and use thereof
JP2016033127A (en) Agent for agricultural and horticultural uses
JP2012250961A (en) Azole derivative, its production method therefor, intermediate compound of the derivative, and agricultural or horticultural chemical and industrial material protectant containing the derivative
JP2012219020A (en) 5-methyl-3(2h)-isoxazolone derivative, and agricultural and horticultural chemical containing the same
WO2012165498A1 (en) Triazole compound and use thereof
JP2012250942A (en) Forage disease controlling agent and method for controlling plant disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12855003

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12855003

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP